PRIOR PRINTER'S NOS. 577, 926, 3911,          PRINTER'S NO. 4238
        3915

THE GENERAL ASSEMBLY OF PENNSYLVANIA


HOUSE BILL

No. 544 Session of 1995


        INTRODUCED BY ALLEN, BOYES, TRELLO, NYCE, BELFANTI, PHILLIPS,
           ARGALL, FAIRCHILD, CLARK, JAMES, MAITLAND, TULLI, MICOZZIE,
           M. COHEN, STABACK, FICHTER, OLASZ, PETRONE, KAISER, HORSEY,
           MASLAND, LYNCH, VAN HORNE, McCALL, RAYMOND, BROWN, BUNT,
           MARKOSEK, HENNESSEY, CIVERA, BROWNE, HESS, GEIST, SEMMEL,
           DENT, MERRY, D. W. SNYDER, KING, HARHART, HUTCHINSON, ZUG,
           HANNA, SCRIMENTI, HABAY, RUBLEY, GANNON, SAYLOR, GRUPPO AND
           NAILOR, FEBRUARY 2, 1995

        AMENDMENTS TO SENATE AMENDMENTS, HOUSE OF REPRESENTATIVES,
           NOVEMBER 18, 1996

                                     AN ACT

     1  Amending the act of August 26, 1971 (P.L.351, No.91), entitled    <--
     2     "An act providing for a State Lottery and administration
     3     thereof; authorizing the creation of a State Lottery
     4     Commission; prescribing its powers and duties; disposition of
     5     funds; violations and penalties therefor; exemption of prizes
     6     from State and local taxation and making an appropriation,"
     7     further providing for the powers and duties of the Secretary
     8     of Revenue and for assignability of prizes drawn; providing
     9     for a temporary PACE moratorium; and making a repeal.
    10  AMENDING THE ACT OF AUGUST 26, 1971 (P.L.351, NO.91), ENTITLED    <--
    11     "AN ACT PROVIDING FOR A STATE LOTTERY AND ADMINISTRATION
    12     THEREOF; AUTHORIZING THE CREATION OF A STATE LOTTERY
    13     COMMISSION; PRESCRIBING ITS POWERS AND DUTIES; DISPOSITION OF
    14     FUNDS; VIOLATIONS AND PENALTIES THEREFOR; EXEMPTION OF PRIZES
    15     FROM STATE AND LOCAL TAXATION AND MAKING AN APPROPRIATION,"
    16     TRANSFERRING PROVISIONS RELATING TO THE STATE LOTTERY FUND;
    17     PROVIDING FOR PHARMACEUTICAL ASSISTANCE FOR THE ELDERLY, FOR
    18     TRANSPORTATION ASSISTANCE TO THE ELDERLY AND FOR
    19     PHARMACEUTICAL PURCHASING; CONFERRING POWERS AND DUTIES UPON
    20     THE DEPARTMENT OF AGING, THE DEPARTMENT OF REVENUE AND THE
    21     DEPARTMENT OF TRANSPORTATION; IMPOSING PENALTIES; MAKING
    22     EDITORIAL CHANGES; AND MAKING REPEALS.
    23                         TABLE OF CONTENTS
    24  CHAPTER 1.  GENERAL PROVISIONS
    25  SECTION 101.  SHORT TITLE.
    26  CHAPTER 3.  STATE LOTTERY


     1  SECTION 301.  STATEMENT OF PURPOSE.
     2  SECTION 302.  DEFINITIONS.
     3  SECTION 303.  POWERS AND DUTIES OF SECRETARY.
     4  SECTION 304.  COMMERCIAL ADVERTISING.
     5  SECTION 305.  LOTTERY SALES AGENTS.
     6  SECTION 306.  ASSIGNABILITY OF PRIZES DRAWN.
     7  SECTION 307.  TICKET SALES.
     8  SECTION 308.  COMPACT TO SELL TICKETS.
     9  SECTION 309.  CERTAIN SALES PROHIBITED.
    10  SECTION 310.  OTHER LAWS INAPPLICABLE.
    11  SECTION 311.  DISPOSITION OF FUNDS.
    12  SECTION 312.  TAX EXEMPTION.
    13  SECTION 313.  UNCLAIMED PRIZE MONEY.
    14  SECTION 314.  DEPOSITS AND TRANSACTIONS.
    15  CHAPTER 5.  PHARMACEUTICAL ASSISTANCE FOR THE ELDERLY
    16  SECTION 501.  LEGISLATIVE FINDINGS.
    17  SECTION 502.  DEFINITIONS.
    18  SECTION 503.  DETERMINATION OF ELIGIBILITY.
    19  SECTION 504.  PHYSICIAN AND PHARMACY PARTICIPATION.
    20  SECTION 505.  DRUG UTILIZATION REVIEW SYSTEM.
    21  SECTION 506.  REDUCED ASSISTANCE.
    22  SECTION 507.  REBATES FOR EXPENSES PROHIBITED.
    23  SECTION 508.  REQUEST FOR PROPOSAL.
    24  SECTION 509.  PROGRAM GENERALLY.
    25  SECTION 510.  GENERIC DRUGS.
    26  SECTION 511.  SUPPLY.
    27  SECTION 512.  RESTRICTED FORMULARY.
    28  SECTION 513.  MAIL ORDER SYSTEM.
    29  SECTION 514.  INDICATION OF PRICE.
    30  SECTION 515.  REIMBURSEMENT.
    31  SECTION 516.  NONLIABILITY.
    32  SECTION 517.  INCOME VERIFICATION.
    33  SECTION 518.  CONTRACT.
    34  SECTION 519.  THE PHARMACEUTICAL ASSISTANCE CONTRACT FOR THE
    35                 ELDERLY NEEDS ENHANCEMENT TIER.
    36  SECTION 520.  BOARD.
    37  SECTION 521.  PENALTIES.
    38  SECTION 522.  PRESCRIPTION DRUG EDUCATION PROGRAM.
    39  CHAPTER 7.  PRUDENT PHARMACEUTICAL PURCHASING
    40  SECTION 701.  DECLARATION OF POLICY.
    41  SECTION 702.  DEFINITIONS.
    42  SECTION 703.  REBATE AGREEMENT.
    43  SECTION 704.  TERMS OF REBATE AGREEMENT.
    44  SECTION 705.  AMOUNT OF REBATE.
    45  SECTION 706.  EXCESSIVE PHARMACEUTICAL PRICE INFLATION
    46                 DISCOUNT.
    47  SECTION 707.  LOWERED BEST PRICE.
    48  SECTION 708.  EXEMPTION.
    49  SECTION 709.  DISPOSITION OF FUNDS.
    50  CHAPTER 9.  TRANSPORTATION SERVICES
    51  SECTION 901.  DEFINITIONS.
    52  SECTION 902.  DEPARTMENT OF TRANSPORTATION.
    53  SECTION 903.  COMMUTER RAIL FARE.
    54  SECTION 904.  SHARED-RIDE TRANSPORTATION.
    55  SECTION 905.  GRANTS.
    56  CHAPTER 21.  MISCELLANEOUS PROVISIONS
    57  SECTION 2101.  SAVINGS.
    58  SECTION 2102.  REPORT.

    59     The General Assembly of the Commonwealth of Pennsylvania
    19950H0544B4238                  - 2 -

     1  hereby enacts as follows:
     2     Section 1.  Sections 6(a)(5) and 8 of the act of August 26,    <--
     3  1971 (P.L.351, No.91), known as the State Lottery Law, are
     4  amended to read:
     5     Section 6.  Powers and Duties of the Secretary of Revenue.--
     6  (a)  In addition to the powers and duties provided by law and
     7  "The Administrative Code of 1929," the Secretary of Revenue
     8  shall have the power and it shall be his duty to operate and
     9  administer the lottery, and to promulgate rules and regulations
    10  governing the establishment and operation thereof, including but
    11  not limited to:
    12     * * *
    13     (5)  The manner of payment of prizes to the holders of
    14  winning tickets or shares: Provided, however, That for new non-
    15  multistate on-line, parimutuel games with prizes of one million
    16  dollars ($1,000,000) or more and payable in more than one
    17  installment, the player shall have the option at the time of
    18  purchase to accept, as full payment of the player's share of the
    19  prize won, a lump sum of the prize money allocated to the first
    20  place prize category, divided equally by the number of tickets
    21  determined by the lottery to be entitled to claim a first place
    22  prize: Provided, That the player specified the lump-sum option
    23  at the time of purchase and received a mark on the ticket
    24  confirming such request. In such cases where the prize pool for
    25  the first place prize is not sufficient to fund the guaranteed
    26  lump-sum prize as announced by the lottery, the prize pool shall
    27  be increased as necessary by the lottery. Players shall be bound
    28  by their pre-winning choice.
    29     * * *
    30     Section 8.  Assignability of Prizes Drawn.--[No] (a)  The
    19950H0544B4238                  - 3 -

     1  right of any person to a prize drawn shall be assignable[,
     2  except that payment] under the following limited circumstances:
     3     (1)  Payment of any prize drawn may be paid to the estate of
     4  a deceased prize winner[, and, except that].
     5     (2)  Payment of any prize drawn may be made to any person
     6  pursuant to an appropriate judicial order. [may be paid the
     7  prize to which the winner is entitled. The secretary shall be
     8  discharged of all further liability upon payment of a prize
     9  pursuant to this section.]
    10     (3)  Payment of any prize drawn may be made to any person
    11  pursuant to a voluntary assignment of the right to receive
    12  future prize payments, in whole or in part, if the assignment is
    13  made to a person or entity designated pursuant to an appropriate
    14  judicial order of the court of common pleas located in either
    15  the judicial district where the assignor resides or where the
    16  division's headquarters are located. Under this paragraph, the
    17  court shall issue an order approving the assignment and
    18  directing the secretary to pay the assignee all future prize
    19  payments, in whole or in part, if:
    20     (i)  the assignment is in writing, executed by the assignor
    21  and subject to the laws of this Commonwealth;
    22     (ii)  the assignor provides a sworn affidavit to the court
    23  attesting that the assignor is of sound mind, is not acting
    24  under duress, has been advised regarding the assignment by his
    25  or her own independent legal counsel and understands and agrees
    26  that with regard to the assigned payments, the Commonwealth and
    27  the secretary will have no further liability or responsibility
    28  to make said payments to the assignor; and
    29     (iii)  the proposed assignment does not include or cover
    30  payments or portions of payments alleged to be subject to offset
    19950H0544B4238                  - 4 -

     1  under judicial order, unless appropriate provision is made in
     2  the order to satisfy the obligations giving rise to the claim
     3  for offset, or to offset under any other statute.
     4     (b)  The secretary shall be discharged of all further
     5  liability upon payment of a prize pursuant to this section.
     6     (c)  Soliciting or offering rights to lottery prize winnings,
     7  either by assignment or through pledge as collateral for a loan,
     8  shall not be deemed selling or offering for sale lottery tickets
     9  or shares under this act. Selling or offering for sale assigned
    10  or pledged lottery prizewinnings shall not be deemed selling or
    11  offering for sale an interest under section 9(c).
    12     (d)  The secretary is authorized to establish a reasonable
    13  fee to defray any administrative expenses associated with
    14  assignments made pursuant to this section, including the cost to
    15  the Commonwealth of any processing fee that may be imposed by a
    16  private annuity provider. The fee amount shall reflect the
    17  direct and indirect costs associated with processing the
    18  assignments.
    19     (e)  Upon a voluntary assignment pursuant to appropriate
    20  judicial order under subsection (a)(3) of payments due to a
    21  prizewinner under a private annuity policy that has been
    22  purchased by the lottery for the benefit of a prize winner, the
    23  Commonwealth and the secretary shall be discharged of and from
    24  any and all liability for the payments or portions thereof
    25  assigned and, as to the payments or portions thereof assigned,
    26  the assignee shall have recourse only against the private
    27  annuity provider and its guarantors and shall have no further
    28  recourse against the Commonwealth.
    29     Section 2.  The act is amended by adding a section to read:
    30     Section 15.1.  Temporary PACE Moratorium.--(a)
    19950H0544B4238                  - 5 -

     1  Notwithstanding any other provision of law to the contrary,
     2  persons who, as of December 31, 1995, were enrolled in the PACE
     3  program established pursuant to the act of August 14, 1991
     4  (P.L.342, No.36), known as the "Lottery Fund Preservation Act,"
     5  shall be eligible for reenrollment in the PACE program,
     6  commencing on the effective date of this section. Enrollment in
     7  the PACE program pursuant to this section shall expire on
     8  December 31, 1996.
     9     (b)  This section shall expire December 31, 1996.
    10     Section 3.  (a)  Section 303(h)(9)(v) of the act of August
    11  14, 1991 (P.L.342, No.36), known as the Lottery Fund
    12  Preservation Act, is repealed.
    13     (b)  All other acts and parts of acts are repealed insofar as
    14  they are inconsistent with this act.
    15     Section 4.  This act shall take effect as follows:
    16         (1)  The addition of section 15.1 of the act and this
    17     section shall take effect immediately.
    18         (2)  The remainder of this act shall take effect in 60
    19     days.
    20     SECTION 1.  SECTIONS 1, 2, 3, 6, 6.1, 7, 8, 9, 9.1, 10, 11,    <--
    21  12, 12.1, 13, 14, 15, 16 AND 17 OF THE ACT OF AUGUST 26, 1971
    22  (P.L.351, NO.91), KNOWN AS THE STATE LOTTERY LAW, AMENDED OR
    23  ADDED OCTOBER 17, 1980 (P.L.1088, NO.184), DECEMBER 15, 1982
    24  (P.L.1288, NO.291), DECEMBER 14, 1992 (P.L.868, NO.138) AND MAY
    25  20, 1993 (P.L.27, NO.8), ARE AMENDED AND CHAPTER HEADINGS AND A
    26  SECTION ARE ADDED TO READ:
    27                             CHAPTER 1
    28                         GENERAL PROVISIONS
    29     [SECTION 1.  SHORT TITLE.--THIS ACT SHALL BE KNOWN AND MAY BE
    30  CITED AS THE "STATE LOTTERY LAW."]
    19950H0544B4238                  - 6 -

     1  SECTION 101.  SHORT TITLE.
     2     THIS ACT SHALL BE KNOWN AND MAY BE CITED AS THE STATE LOTTERY
     3  LAW.
     4                             CHAPTER 3
     5                           STATE LOTTERY
     6     [SECTION 2.  STATEMENT OF PURPOSE.--THIS ACT IS ENACTED TO]
     7  SECTION 301.  STATEMENT OF PURPOSE.
     8     THIS CHAPTER IS ENACTED TO ESTABLISH A LOTTERY TO BE OPERATED
     9  BY THE STATE, THE NET PROCEEDS OF WHICH ARE TO BE USED AFTER
    10  JUNE 30, 1972, FOR THE PURPOSES OF PROVIDING PROPERTY TAX RELIEF
    11  FOR THE ELDERLY FOR TAXES PAID IN 1971 AND THEREAFTER TO PERSONS
    12  [SIXTY-FIVE] 65 YEARS OF AGE OR OLDER AND FOR PROVIDING CERTAIN
    13  FREE FIXED ROUTE LOCAL TRANSIT SERVICES TO PERSONS [SIXTY-FIVE]
    14  65 YEARS OF AGE OR OLDER AND REDUCED FARE ON GROUP RIDE TRANSIT
    15  SERVICE TO PERSONS [SIXTY-FIVE] 65 YEARS OF AGE OR OLDER. IT IS
    16  FURTHER INTENDED TO PROVIDE A MEANS THROUGH WHICH TO CURB
    17  ILLEGAL GAMBLING OPERATIONS IN PENNSYLVANIA.
    18     [SECTION 3.  DEFINITIONS.--AS USED IN THIS ACT:
    19     (2)  "DIVISION" SHALL MEAN THE DIVISION OF THE STATE LOTTERY
    20  CREATED BY THIS ACT.
    21     (3)  "LOTTERY" OR "STATE LOTTERY" SHALL MEAN THE LOTTERY
    22  ESTABLISHED AND OPERATED PURSUANT TO THIS ACT.
    23     (4)  "DIRECTOR" SHALL MEAN THE DIRECTOR OF THE DIVISION OF
    24  THE STATE LOTTERY.
    25     (5)  "SECRETARY" SHALL MEAN THE SECRETARY OF REVENUE.]
    26  SECTION 302.  DEFINITIONS.
    27     THE FOLLOWING WORDS AND PHRASES WHEN USED IN THIS CHAPTER
    28  SHALL HAVE THE MEANINGS GIVEN TO THEM IN THIS SECTION UNLESS THE
    29  CONTEXT CLEARLY INDICATES OTHERWISE:
    30     "DIRECTOR."  THE DIRECTOR OF THE DIVISION OF THE STATE
    19950H0544B4238                  - 7 -

     1  LOTTERY.
     2     "DIVISION."  THE DIVISION OF THE STATE LOTTERY CREATED BY
     3  THIS CHAPTER.
     4     "LOTTERY" OR "STATE LOTTERY."  THE LOTTERY ESTABLISHED AND
     5  OPERATED UNDER THIS CHAPTER.
     6     "SECRETARY."  THE SECRETARY OF REVENUE OF THE COMMONWEALTH.
     7     [SECTION 6.  POWERS AND DUTIES OF THE SECRETARY OF REVENUE.--
     8  (A)  IN]
     9  SECTION 303.  POWERS AND DUTIES OF SECRETARY.
    10     (A)  POWERS AND DUTIES ENUMERATED.--IN ADDITION TO THE POWERS
    11  AND DUTIES PROVIDED BY LAW AND ["THE ADMINISTRATIVE CODE OF
    12  1929,"] THE ACT OF APRIL 9, 1929 (P.L.177, NO.175), KNOWN AS THE
    13  ADMINISTRATIVE CODE OF 1929, THE [SECRETARY OF REVENUE]
    14  SECRETARY SHALL HAVE THE POWER AND IT SHALL BE HIS DUTY TO
    15  OPERATE AND ADMINISTER THE LOTTERY, AND TO PROMULGATE RULES AND
    16  REGULATIONS GOVERNING THE ESTABLISHMENT AND OPERATION THEREOF,
    17  INCLUDING, BUT NOT LIMITED TO:
    18         (1)  THE TYPE OF LOTTERY TO BE CONDUCTED.
    19         (2)  THE PRICE, OR PRICES, OF TICKETS OR SHARES IN THE
    20     LOTTERY.
    21         (3)  THE NUMBERS AND SIZES OF THE PRIZES ON THE WINNING
    22     TICKETS OR SHARES.
    23         (4)  THE MANNER OF SELECTING THE WINNING TICKETS OR
    24     SHARES.
    25         (5)  [THE] (I)  EXCEPT AS PROVIDED IN SUBPARAGRAPH (II),
    26         THE MANNER OF PAYMENT OF PRIZES TO THE HOLDERS OF WINNING
    27         TICKETS OR SHARES.
    28             (II)  FOR NEW NONMULTISTATE ON-LINE, PARIMUTUEL GAMES
    29         WITH PRIZES OF $1,000,000 OR MORE AND PAYABLE IN MORE
    30         THAN ONE INSTALLMENT, THE PLAYER SHALL HAVE THE OPTION AT
    19950H0544B4238                  - 8 -

     1         THE TIME OF PURCHASE TO ACCEPT, AS FULL PAYMENT OF THE
     2         PLAYER'S SHARE OF THE PRIZE WON, A LUMP SUM OF THE PRIZE
     3         MONEY ALLOCATED TO THE FIRST PLACE PRIZE CATEGORY,
     4         DIVIDED EQUALLY BY THE NUMBER OF TICKETS DETERMINED BY
     5         THE LOTTERY TO BE ENTITLED TO CLAIM A FIRST PLACE PRIZE,
     6         PROVIDED THAT THE PLAYER SPECIFIED THE LUMP-SUM OPTION AT
     7         THE TIME OF PURCHASE AND RECEIVED A MARK ON THE TICKET
     8         CONFIRMING SUCH REQUEST. IN CASES WHERE THE PRIZE POOL
     9         FOR THE FIRST PLACE PRIZE IS NOT SUFFICIENT TO FUND THE
    10         GUARANTEED LUMP-SUM PRIZE AS ANNOUNCED BY THE LOTTERY,
    11         THE PRIZE POOL SHALL BE INCREASED AS NECESSARY BY THE
    12         LOTTERY. PLAYERS SHALL BE BOUND BY THEIR PREWINNING
    13         CHOICE.
    14         (6)  THE FREQUENCY OF THE DRAWINGS OR SELECTIONS OF
    15     WINNING TICKETS OR SHARES, WITHOUT LIMITATION.
    16         (7)  WITHOUT LIMIT AS TO NUMBER, THE TYPE OR TYPES OF
    17     LOCATIONS AT WHICH TICKETS OR SHARES MAY BE SOLD.
    18         (8)  THE METHOD TO BE USED IN SELLING TICKETS OR SHARES.
    19         (9)  THE LICENSING OF AGENTS TO SELL TICKETS OR SHARES
    20     PROVIDED THAT NO PERSON UNDER THE AGE OF [TWENTY-ONE] 21
    21     SHALL BE LICENSED AS AN AGENT.
    22         (10)  THE MANNER AND AMOUNT OF COMPENSATION, IF ANY, TO
    23     BE PAID LICENSED SALES AGENTS NECESSARY TO PROVIDE FOR THE
    24     ADEQUATE AVAILABILITY OF TICKETS OR SHARES TO PROSPECTIVE
    25     BUYERS AND FOR THE CONVENIENCE OF THE PUBLIC.
    26         (11)  THE APPORTIONMENT OF THE TOTAL REVENUES ACCRUING
    27     FROM THE SALE OF LOTTERY TICKETS OR SHARES AND FROM ALL OTHER
    28     SOURCES AMONG:
    29             (I)  THE PAYMENT OF PRIZES TO THE HOLDERS OF WINNING
    30         TICKETS OR SHARES;
    19950H0544B4238                  - 9 -

     1             (II)  THE PAYMENT OF COSTS INCURRED IN THE OPERATION
     2         AND ADMINISTRATION OF THE LOTTERY, INCLUDING THE EXPENSES
     3         OF THE DIVISION AND THE COSTS RESULTING FROM ANY CONTRACT
     4         OR CONTRACTS ENTERED INTO FOR PROMOTIONAL, ADVERTISING OR
     5         OPERATIONAL SERVICES OR FOR THE PURCHASE OR LEASE OF
     6         LOTTERY EQUIPMENT AND MATERIALS; AND
     7             [(III) FOR THE REPAYMENT OF THE MONEYS APPROPRIATED
     8         TO THE STATE LOTTERY FUND PURSUANT TO SECTION 16 OF THIS
     9         ACT; AND]
    10             (IV)  FOR PROPERTY TAX RELIEF AND FREE OR REDUCED
    11         FARE TRANSIT SERVICE FOR THE ELDERLY AS PROVIDED IN
    12         SECTION [12 OF THIS ACT: PROVIDED, HOWEVER, THAT NO] 311.
    13         NO LESS THAN [THIRTY PER CENT] 30% OF THE TOTAL REVENUES
    14         ACCRUING FROM THE SALE OF LOTTERY TICKETS OR SHARES SHALL
    15         BE DEDICATED TO [SUBCLAUSE (IV) ABOVE] THIS SUBPARAGRAPH.
    16         (11.1)  THE PRODUCTION AND MERCHANDISING OF PROMOTIONAL
    17     ITEMS FOR THE LOTTERY.
    18         (12)  SUCH OTHER MATTERS NECESSARY OR DESIRABLE FOR THE
    19     EFFICIENT AND ECONOMICAL OPERATION AND ADMINISTRATION OF THE
    20     LOTTERY AND FOR THE CONVENIENCE OF THE PURCHASERS OF TICKETS
    21     OR SHARES AND THE HOLDERS OF WINNING TICKETS OR SHARES.
    22         (13)  THE PERFORMANCE OF THE POWERS AND DUTIES HERETOFORE
    23     VESTED IN THE STATE LOTTERY COMMISSION.
    24     (B)  [TO] REPORTS.--THE SECRETARY SHALL REPORT MONTHLY TO THE
    25  GOVERNOR AND THE LEGISLATURE THE TOTAL LOTTERY REVENUES, PRIZE
    26  DISBURSEMENTS AND OTHER EXPENSES FOR THE PRECEDING MONTH, AND
    27  [TO] SHALL MAKE AN ANNUAL REPORT, WHICH SHALL INCLUDE A FULL AND
    28  COMPLETE STATEMENT OF LOTTERY REVENUES, PRIZE DISBURSEMENTS AND
    29  OTHER EXPENSES, TO THE GOVERNOR AND THE LEGISLATURE, AND
    30  INCLUDING SUCH RECOMMENDATIONS FOR CHANGES IN THIS [ACT] CHAPTER
    19950H0544B4238                 - 10 -

     1  AS THE SECRETARY DEEMS NECESSARY OR DESIRABLE.
     2     [SECTION 6.1.  COMMERCIAL ADVERTISING.--(A)  THE SECRETARY
     3  MAY]
     4  SECTION 304.  COMMERCIAL ADVERTISING.
     5     (A)  GENERAL RULE.--THE SECRETARY MAY ENTER INTO CONTRACTS
     6  WITH PERSONS, ASSOCIATIONS OR CORPORATIONS THAT PROVIDE FOR THE
     7  PLACEMENT OF COMMERCIAL ADVERTISEMENTS ON TICKETS OR SHARES.
     8     (B)  CONTRACTS.--THE SECRETARY MAY ENTER INTO THE CONTRACTS
     9  ONLY AFTER COMPLETION OF THE BIDDING PROCEDURE CONTAINED IN
    10  SUBSECTION (C).
    11     (C)  BIDDING PROCEDURES.--
    12         (1)  THE SECRETARY SHALL, NOT LESS THAN SIX WEEKS PRIOR
    13     TO THE DATE SET FOR OPENING BIDS OR PROPOSALS TO PLACE
    14     ADVERTISEMENTS ON THE TICKETS OR SHARES, ADVERTISE THE
    15     OPENING OF PROPOSALS FOR AT LEAST THREE DAYS, THE FIRST AND
    16     LAST PUBLICATION TO BE AT LEAST TEN DAYS APART, IN NOT FEWER
    17     THAN SIX NOR MORE THAN [TWELVE] 12 NEWSPAPERS OF EXTENSIVE
    18     GENERAL CIRCULATION IN DIFFERENT PARTS OF THIS COMMONWEALTH.
    19     THE ADVERTISEMENTS SHALL INVITE PROPOSALS FOR THE PLACEMENT
    20     OF COMMERCIAL ADVERTISEMENTS ON THE TICKETS OR SHARES, SHALL
    21     DIRECT POTENTIAL BIDDERS TO INCLUDE WITH THEIR PROPOSALS A
    22     SPECIMEN ADVERTISEMENT AND SHALL GIVE NOTICE OF THE TIME AND
    23     PLACE WHERE THE PROPOSALS WILL BE RECEIVED AND WHEN THEY WILL
    24     BE OPENED.
    25         (2)  ALL PROPOSALS SHALL BE DELIVERED TO THE SECRETARY ON
    26     OR BEFORE THE HOUR DESIGNATED IN THE INVITATION TO BID, ON
    27     THE DAY SET BY THE SECRETARY, FOLLOWING THE DATE OF THE LAST
    28     ADVERTISEMENT, AND EACH BID SHALL BE IN DUPLICATES, ONE OF
    29     WHICH SHALL BE MARKED "DUPLICATE BID." EACH BID SHALL BE
    30     ENCLOSED IN AN ENVELOPE, SECURELY SEALED, AND SHALL BE MAILED
    19950H0544B4238                 - 11 -

     1     OR DELIVERED TO THE SECRETARY WHO SHALL RETAIN ALL ENVELOPES
     2     UNOPENED UNTIL THE TIME FIXED FOR THE OPENING THEREOF.
     3         (3)  THE SECRETARY SHALL, ON THE DATE FIXED FOR OPENING
     4     OF BIDS, AT THE HOUR DESIGNATED IN THE INVITATION TO BID,
     5     OPEN AND PUBLISH THE PROPOSALS AND, AS SOON THEREAFTER AS
     6     PRACTICABLE, AWARD THE CONTRACT TO THE HIGHEST RESPONSIBLE
     7     BIDDER. THE SECRETARY SHALL HAVE THE RIGHT TO REJECT ANY OR
     8     ALL BIDS. THE BIDS, WHEN OPENED, SHALL BE TABULATED AND SHALL
     9     BE SUBJECT TO EXAMINATION BY BIDDERS. A RECORD OF ALL BIDS
    10     SHALL BE MADE BY THE SECRETARY IN A BOOK KEPT FOR THAT
    11     PURPOSE.
    12         (4)  WHEN NO PROPOSAL HAS BEEN RECEIVED OR IF FOR ANY
    13     REASON THE SECRETARY REJECTS ALL PROPOSALS, THE SECRETARY MAY
    14     ADVERTISE AGAIN FOR PROPOSALS, GIVING AT LEAST [FIFTEEN] 15
    15     DAYS' NOTICE OF THE TIME OF RECEIVING THE SAME, WHICH
    16     PROPOSALS SHALL BE OPENED, AWARDED AND APPROVED IN LIKE
    17     MANNER AS THE INITIAL BIDS.
    18         (5)  THE SECRETARY SHALL HAVE THE DISCRETION TO REFUSE TO
    19     ACCEPT ANY ADVERTISEMENT THAT IS INAPPROPRIATE OR OFFENSIVE
    20     OR DISPLAYS POOR TASTE. ADVERTISEMENTS FOR TOBACCO PRODUCTS
    21     OR FOR ALCOHOLIC BEVERAGES SHALL NOT BE ACCEPTED.
    22     (D)  DISPOSITION OF REVENUES.--ALL REVENUES DERIVED FROM
    23  CONTRACTS ENTERED INTO UNDER THIS SECTION SHALL BE DEPOSITED IN
    24  THE STATE LOTTERY FUND.
    25     (E)  REGULATIONS.--THE SECRETARY MAY PROMULGATE RULES AND
    26  REGULATIONS TO IMPLEMENT THE PROVISIONS OF THIS SECTION.
    27     (F)  DEFINITION.--AS USED IN THIS SECTION, THE TERM "TICKETS
    28  OR SHARES" SHALL NOT INCLUDE INSTANT GAME TICKETS.
    29     [SECTION 7.  LOTTERY SALES AGENTS; QUALIFICATIONS;
    30  PROHIBITIONS.--(A)  NO LICENSE AS AN AGENT TO SELL LOTTERY]
    19950H0544B4238                 - 12 -

     1  SECTION 305.  LOTTERY SALES AGENTS.
     2     (A)  LICENSING.--NO LICENSE AS AN AGENT TO SELL LOTTERY
     3  TICKETS OR SHARES SHALL BE ISSUED TO ANY PERSON TO ENGAGE IN
     4  BUSINESS EXCLUSIVELY AS A LOTTERY SALES AGENT. BEFORE ISSUING
     5  SUCH LICENSE THE SECRETARY SHALL CONSIDER SUCH FACTORS AS:
     6         (1)  THE FINANCIAL RESPONSIBILITY AND SECURITY OF THE
     7     PERSON AND HIS BUSINESS OR ACTIVITY[;].
     8         (2)  THE ACCESSIBILITY OF HIS PLACE OF BUSINESS OR
     9     ACTIVITY TO THE PUBLIC[;].
    10         (3)  THE SUFFICIENCY OF EXISTING LICENSES TO SERVE THE
    11     PUBLIC CONVENIENCE[; AND].
    12         (4)  THE VOLUME OF EXPECTED SALES.
    13     [FOR THE PURPOSES OF THIS SECTION, THE TERM "PERSON" SHALL BE
    14  CONSTRUED TO MEAN AND INCLUDE AN INDIVIDUAL, ASSOCIATION,
    15  CORPORATION, CLUB, TRUST, ESTATE, SOCIETY, COMPANY, JOINT-STOCK
    16  COMPANY, RECEIVER, TRUSTEE, ASSIGNEE, REFEREE, OR ANY OTHER
    17  PERSON ACTING IN A FIDUCIARY OR REPRESENTATIVE CAPACITY, WHETHER
    18  APPOINTED BY A COURT OR OTHERWISE, AND ANY COMBINATION OF
    19  INDIVIDUALS. "PERSON" SHALL ALSO BE CONSTRUED TO MEAN AND
    20  INCLUDE ALL DEPARTMENTS, COMMISSIONS, AGENCIES AND
    21  INSTRUMENTALITIES OF THE STATE, INCLUDING COUNTIES AND
    22  MUNICIPALITIES AND AGENCIES AND INSTRUMENTALITIES THEREOF.]
    23     (B)  APPROVAL OF APPLICANT.--IF THE SECRETARY SHALL FIND THAT
    24  THE EXPERIENCE, CHARACTER AND GENERAL FITNESS OF THE APPLICANT
    25  ARE SUCH THAT THE PARTICIPATION OF SUCH PERSON AS A LOTTERY
    26  SALES AGENT WILL BE CONSISTENT WITH THE PUBLIC INTEREST,
    27  CONVENIENCE AND NECESSITY, IT MAY THEREUPON GRANT A LICENSE.
    28     WITHOUT LIMITING THE GENERALITY OF THE FOREGOING, THE
    29  SECRETARY MAY REFUSE TO ISSUE A LICENSE PURSUANT TO THIS
    30  SECTION, OR MAY SUSPEND OR REVOKE A LICENSE SO ISSUED IF IT
    19950H0544B4238                 - 13 -

     1  SHALL FIND THAT THE APPLICANT OR LICENSEE:
     2         (1)  HAS BEEN CONVICTED OF A CRIME INVOLVING MORAL
     3     TURPITUDE.
     4         (2)  HAS ENGAGED IN BOOKMAKING OR OTHER FORM OF ILLEGAL
     5     GAMBLING.
     6         (3)  HAS BEEN FOUND GUILTY OF ANY FRAUD OR
     7     MISREPRESENTATION IN ANY CONNECTION.
     8         (4)  HAS VIOLATED ANY RULE, REGULATION OR ORDER OF THE
     9     SECRETARY.
    10     (C)  DENIAL OF LICENSE.--THE SECRETARY MAY REFUSE TO GRANT A
    11  LICENSE OR MAY SUSPEND OR REVOKE A LICENSE ISSUED PURSUANT TO
    12  THIS SECTION TO A CORPORATION, IF IT SHALL DETERMINE THAT:
    13         (1)  ANY OFFICER, DIRECTOR, MEMBER OR STOCKHOLDER OF SUCH
    14     CORPORATION APPLYING FOR A LICENSE OR OF ANY CORPORATION
    15     WHICH OWNS STOCK IN OR SHARES IN THE PROFITS, OR PARTICIPATES
    16     IN THE MANAGEMENT OF THE AFFAIRS OF SUCH APPLICANT:
    17             (I)  HAS BEEN CONVICTED OF A CRIME INVOLVING MORAL
    18         TURPITUDE[,];
    19             (II)  HAS ENGAGED IN BOOKMAKING OR OTHER FORMS OF
    20         ILLEGAL GAMBLING[,];
    21             (III)  HAS BEEN FOUND GUILTY OF ANY FRAUD OR
    22         MISREPRESENTATION IN ANY CONNECTION[,]; OR
    23             (IV)  HAS VIOLATED ANY RULE, REGULATION OR ORDER OF
    24         THE SECRETARY.
    25         (2)  THE EXPERIENCE, CHARACTER, OR GENERAL FITNESS OF ANY
    26     OFFICER, DIRECTOR, OR STOCKHOLDER OF ANY OF THE AFORESAID
    27     CORPORATIONS IS SUCH THAT THE PARTICIPATION OF SUCH PERSON AS
    28     A LOTTERY SALES AGENT WOULD BE INCONSISTENT WITH THE PUBLIC
    29     INTEREST, CONVENIENCE OR NECESSITY, BUT IF THE SECRETARY
    30     DETERMINES THAT THE INTEREST OF ANY STOCKHOLDER REFERRED TO
    19950H0544B4238                 - 14 -

     1     IN THIS [CLAUSE OR IN CLAUSE (1) OF THIS SUBSECTION]
     2     PARAGRAPH OR IN PARAGRAPH (1) IS SUFFICIENT, IN THE OPINION
     3     OF THE SECRETARY, TO AFFECT ADVERSELY THE CONDUCT OF A
     4     LOTTERY SALES AGENCY BY SUCH CORPORATION IN ACCORDANCE WITH
     5     THE PROVISIONS OF THIS [ACT] CHAPTER, THE SECRETARY MAY
     6     DISREGARD SUCH INTEREST IN DETERMINING WHETHER OR NOT TO
     7     GRANT A LICENSE TO SUCH CORPORATION.
     8         (3)  THE APPLICANT IS NOT THE OWNER OR THE LESSEE OF THE
     9     BUSINESS AT WHICH IT WILL CONDUCT A LOTTERY SALES AGENCY
    10     PURSUANT TO THE LICENSE APPLIED FOR, OR THAT ANY PERSON,
    11     FIRM, ASSOCIATION, OR CORPORATION OTHER THAN THE APPLICANT
    12     SHARES, OR WILL SHARE, IN THE PROFITS OF THE APPLICANT, OTHER
    13     THAN BY DIVIDENDS AS A STOCKHOLDER, OR PARTICIPATES, OR WILL
    14     PARTICIPATE, IN THE MANAGEMENT OF THE AFFAIRS OF THE
    15     APPLICANT.
    16     (D)  TEMPORARY LICENSE.--PENDING FINAL DETERMINATION OF ANY
    17  QUESTION UNDER THIS SECTION, THE SECRETARY MAY ISSUE A TEMPORARY
    18  LICENSE UPON SUCH TERMS AND CONDITIONS AS IT MAY DEEM NECESSARY,
    19  DESIRABLE OR PROPER TO EFFECTUATE THE PROVISIONS OF THIS [ACT]
    20  CHAPTER.
    21     (E)  RESURVEY.--ANY PERSON WHO HAS A PENDING APPLICATION FOR
    22  A LOTTERY MACHINE AND IS CURRENTLY ENGAGED IN THE SALE OF OUT-
    23  OF-STATE LOTTERY TICKETS MAY SUBMIT A WRITTEN REQUEST TO THE
    24  DEPARTMENT OF REVENUE FOR A RESURVEY. THIS RESURVEY SHALL BE
    25  COMPLETED BY THE DEPARTMENT WITHIN [NINETY] 90 DAYS OF RECEIPT
    26  OF THE REQUEST.
    27     (F)  DEFINITION.--AS USED IN THIS SECTION, THE TERM "PERSON"
    28  MEANS AND INCLUDES AN INDIVIDUAL, ASSOCIATION, CORPORATION,
    29  CLUB, TRUST, ESTATE, SOCIETY, COMPANY, JOINT-STOCK COMPANY,
    30  RECEIVER, TRUSTEE, ASSIGNEE, REFEREE, OR ANY OTHER PERSON ACTING
    19950H0544B4238                 - 15 -

     1  IN A FIDUCIARY OR REPRESENTATIVE CAPACITY, WHETHER APPOINTED BY
     2  A COURT OR OTHERWISE, AND ANY COMBINATION OF INDIVIDUALS. THE
     3  TERM SHALL ALSO MEAN AND INCLUDE ALL DEPARTMENTS, COMMISSIONS,
     4  AGENCIES AND INSTRUMENTALITIES OF THE STATE, INCLUDING COUNTIES
     5  AND MUNICIPALITIES AND AGENCIES AND INSTRUMENTALITIES THEREOF.
     6     [SECTION 8.  ASSIGNABILITY OF PRIZES DRAWN.--NO RIGHT OF ANY
     7  PERSON TO A PRIZE DRAWN SHALL BE ASSIGNABLE, EXCEPT THAT PAYMENT
     8  OF ANY PRIZE DRAWN MAY BE PAID TO THE ESTATE OF A DECEASED PRIZE
     9  WINNER, AND, EXCEPT THAT ANY PERSON PURSUANT TO AN APPROPRIATE
    10  JUDICIAL ORDER MAY BE PAID THE PRIZE TO WHICH THE WINNER IS
    11  ENTITLED. THE SECRETARY SHALL BE DISCHARGED OF ALL FURTHER
    12  LIABILITY UPON PAYMENT OF A PRIZE PURSUANT TO THIS SECTION.]
    13  SECTION 306.  ASSIGNABILITY OF PRIZES DRAWN.
    14     (A)  ASSIGNABILITY.--THE RIGHT OF ANY PERSON TO A PRIZE DRAWN
    15  SHALL BE ASSIGNABLE UNDER THE FOLLOWING LIMITED CIRCUMSTANCES:
    16         (1)  PAYMENT OF ANY PRIZE DRAWN MAY BE PAID TO THE ESTATE
    17     OF A DECEASED PRIZE WINNER.
    18         (2)  PAYMENT OF ANY PRIZE DRAWN MAY BE MADE TO ANY PERSON
    19     PURSUANT TO AN APPROPRIATE JUDICIAL ORDER.
    20         (3)  PAYMENT OF ANY PRIZE DRAWN MAY BE MADE TO ANY PERSON
    21     PURSUANT TO A VOLUNTARY ASSIGNMENT OF THE RIGHT TO RECEIVE
    22     FUTURE PRIZE PAYMENTS, IN WHOLE OR IN PART, IF THE ASSIGNMENT
    23     IS MADE TO A PERSON OR ENTITY DESIGNATED PURSUANT TO AN
    24     APPROPRIATE JUDICIAL ORDER OF THE COURT OF COMMON PLEAS
    25     LOCATED IN EITHER THE JUDICIAL DISTRICT WHERE THE ASSIGNOR
    26     RESIDES OR WHERE THE DIVISION'S HEADQUARTERS ARE LOCATED.
    27     UNDER THIS PARAGRAPH, THE COURT SHALL ISSUE AN ORDER
    28     APPROVING THE ASSIGNMENT AND DIRECTING THE SECRETARY TO PAY
    29     THE ASSIGNEE ALL FUTURE PRIZE PAYMENTS, IN WHOLE OR IN PART,
    30     IF:
    19950H0544B4238                 - 16 -

     1             (I)  THE ASSIGNMENT IS IN WRITING, EXECUTED BY THE
     2         ASSIGNOR AND SUBJECT TO THE LAWS OF THIS COMMONWEALTH;
     3             (II)  THE ASSIGNOR PROVIDES A SWORN AFFIDAVIT TO THE
     4         COURT ATTESTING THAT THE ASSIGNOR IS OF SOUND MIND, IS
     5         NOT ACTING UNDER DURESS, HAS BEEN ADVISED REGARDING THE
     6         ASSIGNMENT BY HIS OR HER OWN INDEPENDENT LEGAL COUNSEL
     7         AND UNDERSTANDS AND AGREES THAT, WITH REGARD TO THE
     8         ASSIGNED PAYMENTS, THE COMMONWEALTH AND THE SECRETARY
     9         SHALL HAVE NO FURTHER LIABILITY OR RESPONSIBILITY TO MAKE
    10         SAID PAYMENTS TO THE ASSIGNOR; AND
    11             (III)  THE PROPOSED ASSIGNMENT DOES NOT INCLUDE OR
    12         COVER PAYMENTS OR PORTIONS OF PAYMENTS ALLEGED TO BE
    13         SUBJECT TO OFFSET UNDER JUDICIAL ORDER, UNLESS
    14         APPROPRIATE PROVISION IS MADE IN THE ORDER TO SATISFY THE
    15         OBLIGATIONS GIVING RISE TO THE CLAIM FOR OFFSET, OR TO
    16         OFFSET UNDER ANY OTHER STATUTE.
    17     (B)  DISCHARGE OF SECRETARY.--THE SECRETARY SHALL BE
    18  DISCHARGED OF ALL FURTHER LIABILITY UPON PAYMENT OF A PRIZE
    19  PURSUANT TO THIS SECTION.
    20     (C)  ENFORCEMENT.--SOLICITING OR OFFERING RIGHTS TO LOTTERY
    21  PRIZEWINNINGS, EITHER BY ASSIGNMENT OR THROUGH PLEDGE AS
    22  COLLATERAL FOR A LOAN, SHALL NOT BE DEEMED SELLING OR OFFERING
    23  FOR SALE LOTTERY TICKETS OR SHARES UNDER THIS ACT. SELLING OR
    24  OFFERING FOR SALE ASSIGNED OR PLEDGED LOTTERY PRIZEWINNINGS
    25  SHALL NOT BE DEEMED SELLING OR OFFERING FOR SALE AN INTEREST
    26  UNDER SECTION 307.
    27     (D)  FEES.--THE SECRETARY IS AUTHORIZED TO ESTABLISH A
    28  REASONABLE FEE TO DEFRAY ANY ADMINISTRATIVE EXPENSES ASSOCIATED
    29  WITH ASSIGNMENTS MADE PURSUANT TO THIS SECTION, INCLUDING THE
    30  COST TO THE COMMONWEALTH OF ANY PROCESSING FEE THAT MAY BE
    19950H0544B4238                 - 17 -

     1  IMPOSED BY A PRIVATE ANNUITY PROVIDER. THE FEE AMOUNT SHALL
     2  REFLECT THE DIRECT AND INDIRECT COSTS ASSOCIATED WITH PROCESSING
     3  THE ASSIGNMENTS.
     4     (E)  DISCHARGE OF COMMONWEALTH.--UPON A VOLUNTARY ASSIGNMENT
     5  PURSUANT TO APPROPRIATE JUDICIAL ORDER UNDER SUBSECTION (A)(3)
     6  OF PAYMENTS DUE TO A PRIZEWINNER UNDER A PRIVATE ANNUITY POLICY
     7  THAT HAS BEEN PURCHASED BY THE LOTTERY FOR THE BENEFIT OF A
     8  PRIZEWINNER, THE COMMONWEALTH AND THE SECRETARY SHALL BE
     9  DISCHARGED FROM ANY AND ALL LIABILITY FOR THE PAYMENTS OR
    10  PORTIONS THEREOF ASSIGNED AND, AS TO THE PAYMENTS OR PORTIONS
    11  THEREOF ASSIGNED, THE ASSIGNEE SHALL HAVE RECOURSE ONLY AGAINST
    12  THE PRIVATE ANNUITY PROVIDER AND ITS GUARANTORS AND SHALL HAVE
    13  NO FURTHER RECOURSE AGAINST THE COMMONWEALTH.
    14     (F)  ASSIGNMENT LIMITATION.--NOTWITHSTANDING ANY OTHER
    15  PROVISION OF THIS SECTION, NO PRIZEWINNER SHALL HAVE THE RIGHT
    16  TO ASSIGN PRIZE PAYMENTS UPON:
    17         (1)  THE ISSUANCE BY THE UNITED STATES INTERNAL REVENUE
    18     SERVICE (IRS) OF A TECHNICAL RULE LETTER, REVENUE RULING OR
    19     OTHER PUBLIC RULING OF THE IRS IN WHICH THE IRS DETERMINES
    20     THAT, BASED UPON THE RIGHT OF ASSIGNMENT PROVIDED IN THIS
    21     ACT, A PENNSYLVANIA LOTTERY PRIZEWINNER WHO DOES NOT ASSIGN
    22     ANY PRIZE PAYMENTS PURSUANT TO SUBSECTION (A)(3) WOULD BE
    23     SUBJECT TO AN IMMEDIATE INCOME TAX LIABILITY FOR THE VALUE OF
    24     THE ENTIRE PRIZE RATHER THAN ANNUAL INCOME TAX LIABILITY FOR
    25     EACH INSTALLMENT WHEN PAID.
    26         (2)  THE ISSUANCE BY A COURT OF COMPETENT JURISDICTION OF
    27     A PUBLISHED DECISION HOLDING THAT, BASED UPON THE RIGHT OF
    28     ASSIGNMENT PROVIDED IN THIS ACT, A PENNSYLVANIA LOTTERY
    29     PRIZEWINNER WHO DOES NOT ASSIGN ANY PRIZE PAYMENTS PURSUANT
    30     TO SUBSECTION (A)(3) WOULD BE SUBJECT TO AN IMMEDIATE INCOME
    19950H0544B4238                 - 18 -

     1     TAX LIABILITY FOR THE VALUE OF THE ENTIRE PRIZE RATHER THAN
     2     ANNUAL INCOME TAX LIABILITY FOR EACH INSTALLMENT WHEN PAID.
     3     (G)  FILING OF LETTER DECISION.--UPON RECEIPT OF A LETTER OR
     4  RULING FROM THE IRS OR A PUBLISHED DECISION OF A COURT OF
     5  COMPETENT JURISDICTION, AS SPECIFIED IN SUBSECTION (F), THE
     6  EXECUTIVE DIRECTOR SHALL IMMEDIATELY FILE A COPY OF THAT LETTER,
     7  RULING OR PUBLISHED DECISION WITH THE SECRETARY OF STATE.
     8  IMMEDIATELY UPON THE FILING BY THE DIRECTOR OF A LETTER, RULING
     9  OR PUBLISHED DECISION WITH THE SECRETARY OF STATE, A PRIZEWINNER
    10  SHALL BE INELIGIBLE TO ASSIGN A PRIZE PURSUANT TO SUBSECTION
    11  (A)(3).
    12     [SECTION 9.  SALES OF TICKETS IN EXCESS OF REGULATED PRICE;
    13  SALES BY NON-LICENSED PERSONS; PENALTIES.--(A)  NO PERSON SHALL]
    14  SECTION 307.  TICKET SALES.
    15     (A)  PRICES.--NO PERSON SHALL SELL, RESELL OR ENGAGE IN THE
    16  BUSINESS OF RESELLING LOTTERY TICKETS OR SHARES AT A PRICE
    17  GREATER THAN THAT FIXED BY RULE OR REGULATION OF THE DEPARTMENT.
    18  PRICE SHALL INCLUDE ANY FEE ASSOCIATED WITH THE ACQUISITION OR
    19  TRANSPORTATION OF LOTTERY TICKETS OR SHARES.
    20     (B)  CONSTRUCTION.--NO PERSON OTHER THAN A LICENSED LOTTERY
    21  SALES AGENT SHALL SELL LOTTERY TICKETS OR SHARES, EXCEPT THAT
    22  NOTHING IN THIS SECTION SHALL BE CONSTRUED TO PREVENT ANY PERSON
    23  FROM GIVING LOTTERY TICKETS OR SHARES TO ANOTHER AS A GIFT.
    24     (C)  LOTTERIES OF OTHER STATES.--EXCEPT AS PROVIDED IN THIS
    25  [ACT] CHAPTER, NO PERSON SHALL ENGAGE IN THE SALE OR OFFERING
    26  FOR SALE WITHIN THIS COMMONWEALTH OF ANY INTEREST IN A LOTTERY
    27  OF ANOTHER STATE OR GOVERNMENT WHETHER OR NOT SUCH INTEREST IS
    28  AN ACTUAL LOTTERY TICKET, RECEIPT, CONTINGENT PROMISE TO PAY,
    29  ORDER TO PURCHASE OR OTHER RECORD OF SUCH INTEREST.
    30     (D)  PENALTY.--ANY PERSON CONVICTED OF VIOLATING THIS SECTION
    19950H0544B4238                 - 19 -

     1  SHALL BE GUILTY OF A MISDEMEANOR AND UPON CONVICTION THEREOF,
     2  SHALL BE SENTENCED TO PAY A FINE [NOT EXCEEDING TWO THOUSAND
     3  DOLLARS ($2,000)] OF NOT MORE THAN $2,000.
     4     [SECTION 9.1.  COMPACT TO SELL TICKETS.--THE SECRETARY SHALL]
     5  SECTION 308.  COMPACT TO SELL TICKETS.
     6     THE SECRETARY SHALL ENTER INTO A COMPACT WITH ANY OTHER
     7  STATES THAT PERMIT SALE OF PENNSYLVANIA LOTTERY TICKETS WITHIN
     8  THEIR BORDERS TO SELL THOSE STATES' LOTTERY TICKETS WITHIN THIS
     9  COMMONWEALTH.
    10     [SECTION 10.  SALES TO CERTAIN PERSONS PROHIBITED; PENALTY.--
    11  NO]
    12  SECTION 309.  CERTAIN SALES PROHIBITED.
    13     (A)  MINORS.--
    14         (1)  NO TICKET OR SHARE SHALL BE SOLD TO ANY PERSON UNDER
    15     [THE AGE OF EIGHTEEN YEARS] 18 YEARS OF AGE. FOR THE PURPOSE
    16     OF MAKING A GIFT, A PERSON [EIGHTEEN] 18 YEARS OF AGE OR
    17     OLDER MAY PURCHASE A TICKET OR SHARE FOR THE BENEFIT OF A
    18     PERSON LESS THAN THAT AGE.
    19         (2)  ANY AGENT OR [EMPLOYE] EMPLOYEE OF ANY AGENT WHO
    20     KNOWINGLY SELLS A LOTTERY TICKET OR SHARE TO ANY PERSON UNDER
    21     [THE AGE OF EIGHTEEN YEARS] 18 YEARS OF AGE SHALL BE GUILTY
    22     OF A MISDEMEANOR, AND UPON CONVICTION THEREOF, SHALL BE
    23     SENTENCED TO PAY A FINE [NOT EXCEEDING FIVE HUNDRED DOLLARS
    24     ($500)] OF NOT MORE THAN $500.
    25     (B)  CERTAIN EMPLOYEES.--NO TICKET OR SHARE SHALL BE SOLD TO
    26  AND NO PRIZE SHALL BE AWARDED TO ANY OFFICER OR [EMPLOYE]
    27  EMPLOYEE OF THE [DIVISION OF THE STATE LOTTERY] DIVISION IN THE
    28  DEPARTMENT OF REVENUE OR ANY SPOUSE, CHILD, BROTHER, SISTER OR
    29  PARENT RESIDING AS A MEMBER OF THE SAME HOUSEHOLD IN THE
    30  PRINCIPAL PLACE OF ABODE OF ANY OF THE FOREGOING PERSONS.
    19950H0544B4238                 - 20 -

     1     [SECTION 11.  OTHER LAWS INAPPLICABLE.--NO OTHER LAW
     2  PROVIDING]
     3  SECTION 310.  OTHER LAWS INAPPLICABLE.
     4     NO OTHER LAW PROVIDING ANY PENALTY OR DISABILITY FOR THE SALE
     5  OF LOTTERY TICKETS OR SHARES OR ANY ACTS DONE IN CONNECTION WITH
     6  A LOTTERY SHALL APPLY TO THE SALE OF TICKETS OR SHARES OR ACTS
     7  PERFORMED PURSUANT TO THIS [ACT] CHAPTER.
     8     [SECTION 12.  DISPOSITION OF FUNDS FROM SALE OF TICKETS OR
     9  SHARES.--(A)  ALL MONEYS RECEIVED FROM THE OPERATION OF THE]
    10  SECTION 311.  DISPOSITION OF FUNDS.
    11     (A)  STATE LOTTERY FUND.--ALL MONEYS RECEIVED FROM THE
    12  OPERATION OF THE STATE LOTTERY SHALL BE DEPOSITED IN A STATE
    13  LOTTERY FUND WHICH IS HEREBY CREATED. SUCH MONEYS SHALL BE USED
    14  TO THE EXTENT NECESSARY FOR THE PAYMENT OF LOTTERY PRIZES BUT
    15  THE AMOUNT SO USED SHALL NOT BE LESS THAN [FORTY PER CENT] 40%
    16  OF THE AMOUNT OF WHICH TICKETS OR SHARES HAVE BEEN SOLD. ALL
    17  PAYMENTS OF LOTTERY PRIZES AND FOR EXPENSES OF OPERATION OF THE
    18  LOTTERY SHALL BE MADE AS PROVIDED BY LAW. ALL MONEYS REMAINING
    19  AFTER PAYMENT OF PRIZES AND OPERATING EXPENSES SHALL REMAIN IN
    20  THE STATE LOTTERY FUND AND SHALL BE ALLOCATED FOR THE PURPOSE OF
    21  PROVIDING PROPERTY TAX RELIEF FOR THE ELDERLY FOR TAXES PAID IN
    22  1971 AND THEREAFTER PURSUANT TO THE PROVISIONS OF THE ACT OF
    23  MARCH 11, 1971 (P.L.104, NO.3), KNOWN AS THE ["SENIOR CITIZENS
    24  PROPERTY TAX OR RENT REBATE AND OLDER PERSONS INFLATION NEEDS
    25  ACT,"] SENIOR CITIZENS REBATE AND ASSISTANCE ACT, AND FOR THE
    26  PURPOSE OF PROVIDING FREE OR REDUCED FARE TRANSIT SERVICE FOR
    27  THE ELDERLY PURSUANT TO [THE ACT OF JANUARY 22, 1968 (P.L.42,
    28  NO.8), KNOWN AS THE "PENNSYLVANIA URBAN MASS TRANSPORTATION
    29  ASSISTANCE LAW OF 1967,"] CHAPTER 9 AND THE ACT OF FEBRUARY 11,
    30  1976 (P.L.14, NO.10), KNOWN AS THE ["]PENNSYLVANIA RURAL AND
    19950H0544B4238                 - 21 -

     1  INTERCITY COMMON CARRIER SURFACE TRANSPORTATION ASSISTANCE
     2  ACT.["] IN THE EVENT SUFFICIENT FUNDS ARE NOT AVAILABLE FROM THE
     3  LOTTERY RECEIPTS TO MEET THE REQUIREMENTS OF THE [ACT OF MARCH
     4  11, 1971 (P.L.104, NO.3), KNOWN AS THE "SENIOR CITIZENS PROPERTY
     5  TAX OR RENT REBATE AND OLDER PERSONS INFLATION NEEDS ACT,"]
     6  SENIOR CITIZENS REBATE AND ASSISTANCE ACT OR FOR PROVIDING FREE
     7  OR REDUCED FARE TRANSIT SERVICE FOR THE ELDERLY UNDER [THE ACT
     8  OF JANUARY 22, 1968 (P.L.42, NO.8), KNOWN AS THE "PENNSYLVANIA
     9  URBAN MASS TRANSPORTATION ASSISTANCE LAW OF 1967,"] CHAPTER 9
    10  AND THE [ACT OF FEBRUARY 11, 1976 (P.L.14, NO.10), KNOWN AS THE
    11  "]PENNSYLVANIA RURAL AND INTERCITY COMMON CARRIER SURFACE
    12  TRANSPORTATION ASSISTANCE ACT,["] ADDITIONAL FUNDS TO FULFILL
    13  THESE OBLIGATIONS[,] SHALL BE APPROPRIATED FROM THE GENERAL FUND
    14  FOR THIS PURPOSE.
    15     (B)  APPROPRIATIONS.--THE MONEYS IN SAID STATE LOTTERY FUND
    16  SHALL BE APPROPRIATED ONLY:
    17         (1)  FOR THE PAYMENT OF PRIZES TO THE HOLDERS OF WINNING
    18     LOTTERY TICKETS OR SHARES[;].
    19         (2)  FOR THE EXPENSES OF THE DIVISION IN ITS OPERATION OF
    20     THE LOTTERY[;].
    21         (3)  FOR PROPERTY TAX RELIEF AND FREE OR REDUCED FARE
    22     TRANSIT SERVICE FOR THE ELDERLY AS PROVIDED UNDER [SECTION 12
    23     OF THIS ACT; AND
    24         (4)  FOR TRANSFER TO THE GENERAL FUND THROUGH JUNE 30,
    25     1972, AND FOR THE REPAYMENT TO THE GENERAL FUND OF THE AMOUNT
    26     APPROPRIATED TO THE FUND PURSUANT TO SECTION 16 OF THIS ACT]
    27     SUBSECTION (A).
    28     [SECTION 12.1.  TRANSPORTATION ASSISTANCE GRANT.--FOR THE
    29  FISCAL YEAR 1982-1983 FOUR MILLION ONE HUNDRED THOUSAND DOLLARS
    30  ($4,100,000) IS HEREBY APPROPRIATED FROM THE LOTTERY FUND TO THE
    19950H0544B4238                 - 22 -

     1  DEPARTMENT OF AGING FOR TRANSPORTATION GRANTS TO AREA AGENCIES
     2  ON AGING TO PURCHASE, REPLACE, LEASE, MAINTAIN, OPERATE OR
     3  CONTRACT FOR THE OPERATION OF VEHICLES OR EQUIPMENT FOR USE IN
     4  SENIOR CITIZENS TRANSPORTATION. THE TOTAL AMOUNT TO BE GRANTED
     5  TO EACH AREA AGENCY ON AGING SHALL BE DETERMINED BY THE
     6  FOLLOWING FORMULA:
     7     (TWO MILLION FIFTY THOUSAND DOLLARS X A/B) +
     8     (TWO MILLION FIFTY THOUSAND DOLLARS X C/D)
     9         "A" EQUALS THE NUMBER OF ELDERLY POOR PERSONS RESIDING IN
    10     THE AREA SERVED BY THE AREA AGENCY ON AGING.
    11         "B" EQUALS THE NUMBER OF ELDERLY POOR PERSONS IN
    12     PENNSYLVANIA.
    13         "C" EQUALS THE NUMBER OF SQUARE MILES OF THE AREA SERVED
    14     BY THE AREA AGENCY ON AGING.
    15         "D" EQUALS THE NUMBER OF SQUARE MILES IN PENNSYLVANIA.
    16     THE GRANT SHALL BE IN ADDITION TO THOSE AUTHORIZED UNDER AND
    17  MAY BE USED IN CONJUNCTION WITH SECTION 406 OF THE ACT OF
    18  JANUARY 22, 1968 (P.L.42, NO.8), KNOWN AS THE "PENNSYLVANIA
    19  URBAN MASS TRANSPORTATION LAW."
    20     SECTION 13.  EXEMPTION OF LOTTERY PRIZES FROM STATE AND LOCAL
    21  TAXATION.--NO STATE OR LOCAL TAXES OF ANY KIND WHATSOEVER SHALL]
    22  SECTION 312.  TAX EXEMPTION.
    23     NO STATE OR LOCAL TAXES OF ANY KIND WHATSOEVER SHALL BE
    24  IMPOSED UPON THE PROCEEDS FROM A PRIZE AWARDED BY THE STATE
    25  LOTTERY.
    26     [SECTION 14.  UNCLAIMED PRIZE MONEY.--UNCLAIMED PRIZE MONEY
    27  ON]
    28  SECTION 313.  UNCLAIMED PRIZE MONEY.
    29     UNCLAIMED PRIZE MONEY ON A WINNING LOTTERY TICKET OR SHARE
    30  SHALL BE RETAINED BY THE SECRETARY FOR PAYMENT TO THE PERSON
    19950H0544B4238                 - 23 -

     1  ENTITLED THERETO FOR ONE YEAR AFTER THE DRAWING IN WHICH THE
     2  PRIZE WAS WON. IF NO CLAIM IS MADE WITHIN SUCH PERIOD, THE PRIZE
     3  MONEY SHALL BE PAID INTO THE STATE LOTTERY FUND AND USED FOR
     4  PURPOSES AS OTHERWISE HEREIN PROVIDED.
     5     [SECTION 15.  BANK DEPOSITS AND CONTROL OF LOTTERY
     6  TRANSACTIONS.--THE SECRETARY MAY, IN HIS DISCRETION, REQUIRE
     7  ANY]
     8  SECTION 314.  DEPOSITS AND TRANSACTIONS.
     9     THE SECRETARY MAY, IN HIS DISCRETION, REQUIRE ANY OR ALL
    10  LOTTERY SALES AGENTS TO DEPOSIT TO THE CREDIT OF THE STATE
    11  LOTTERY FUND IN BANKS, DESIGNATED BY THE STATE TREASURER, ALL
    12  MONEYS RECEIVED BY SUCH AGENTS FROM THE SALE OF LOTTERY TICKETS
    13  OR SHARES, LESS THE AMOUNT, IF ANY, RETAINED AS COMPENSATION FOR
    14  THE SALE OF THE TICKETS OR SHARES, AND TO FILE WITH THE
    15  SECRETARY OR HIS DESIGNATED AGENTS REPORTS OF THEIR RECEIPTS AND
    16  TRANSACTIONS IN THE SALE OF LOTTERY TICKETS IN SUCH FORM AND
    17  CONTAINING SUCH INFORMATION AS HE MAY REQUIRE. THE SECRETARY MAY
    18  MAKE SUCH ARRANGEMENTS FOR ANY PERSON, INCLUDING A BANK, TO
    19  PERFORM SUCH FUNCTIONS, ACTIVITIES OR SERVICES IN CONNECTION
    20  WITH THE OPERATION OF THE LOTTERY AS HE MAY DEEM ADVISABLE
    21  PURSUANT TO THIS [ACT] CHAPTER AND THE RULES AND REGULATIONS OF
    22  THE DEPARTMENT, AND SUCH FUNCTIONS, ACTIVITIES OR SERVICES SHALL
    23  CONSTITUTE LAWFUL FUNCTIONS, ACTIVITIES AND SERVICES OF SUCH
    24  PERSON.
    25     [SECTION 16.  APPROPRIATION.--THERE IS HEREBY APPROPRIATED
    26  THE SUM OF ONE MILLION DOLLARS ($1,000,000), OR SO MUCH THEREOF
    27  AS IS NECESSARY FOR THE ESTABLISHMENT OF THE STATE LOTTERY AND
    28  THE DIVISION OF THE STATE LOTTERY IN THE DEPARTMENT OF REVENUE.
    29  THE DEPARTMENT OF REVENUE SHALL REIMBURSE THE GENERAL FUND FROM
    30  RECEIPTS FROM SALE OF LOTTERY TICKETS OR SHARES THE ACTUAL
    19950H0544B4238                 - 24 -

     1  AMOUNT OF MONEY EXPENDED FROM SAID APPROPRIATION WITHIN ONE YEAR
     2  OF THE DATE OF THE FIRST LOTTERY DRAWING.
     3     SECTION 17.  EFFECTIVE DATE.--THIS ACT SHALL TAKE EFFECT
     4  IMMEDIATELY.]
     5     SECTION 2.  THE ACT IS AMENDED BY ADDING CHAPTERS TO READ:
     6                             CHAPTER 5
     7             PHARMACEUTICAL ASSISTANCE FOR THE ELDERLY
     8  SECTION 501.  LEGISLATIVE FINDINGS.
     9     FINDING THAT AN INCREASING NUMBER OF THE COMMONWEALTH'S
    10  ELDERLY CITIZENS WHO ARE LIVING ON FIXED INCOMES ARE
    11  EXPERIENCING DIFFICULTIES IN MEETING THE COSTS OF LIFE-
    12  SUSTAINING PRESCRIPTION DRUGS, THE GENERAL ASSEMBLY, IN ITS
    13  RESPONSIBILITIES TO PROVIDE FOR THE HEALTH, WELFARE AND SAFETY
    14  OF THE RESIDENTS OF THIS COMMONWEALTH, HEREBY CONTINUES A
    15  LIMITED STATE PHARMACEUTICAL ASSISTANCE PROGRAM FOR THE ELDERLY.
    16  SECTION 502.  DEFINITIONS.
    17     THE FOLLOWING WORDS AND PHRASES WHEN USED IN THIS CHAPTER
    18  SHALL HAVE THE MEANINGS GIVEN TO THEM IN THIS SECTION UNLESS THE
    19  CONTEXT CLEARLY INDICATES OTHERWISE:
    20     "A-RATED GENERIC THERAPEUTICALLY EQUIVALENT DRUG."  A DRUG
    21  PRODUCT THAT THE COMMISSIONER OF FOOD AND DRUGS OF THE UNITED
    22  STATES FOOD AND DRUG ADMINISTRATION HAS APPROVED AS SAFE AND
    23  EFFECTIVE AND HAS DETERMINED TO BE THERAPEUTICALLY EQUIVALENT,
    24  AS LISTED IN "THE APPROVED DRUG PRODUCTS WITH THERAPEUTIC
    25  EQUIVALENCE EVALUATIONS" (FOOD AND DRUG ADMINISTRATION "ORANGE
    26  BOOK"), WITH A SPECIFIC "A" CODE DESIGNATION ONLY.
    27     "AVERAGE WHOLESALE COST."  THE COST OF A DISPENSED DRUG BASED
    28  UPON THE PRICE PUBLISHED IN A NATIONAL DRUG PRICING SYSTEM IN
    29  CURRENT USE BY THE DEPARTMENT OF AGING AS THE AVERAGE WHOLESALE
    30  PRICE OF A PRESCRIPTION DRUG IN THE MOST COMMON PACKAGE SIZE.
    19950H0544B4238                 - 25 -

     1     "AVERAGE WHOLESALE PRICE."  AVERAGE WHOLESALE COST.
     2     "BOARD."  THE PHARMACEUTICAL ASSISTANCE REVIEW BOARD.
     3     "DEPARTMENT."  THE DEPARTMENT OF AGING OF THE COMMONWEALTH.
     4     "ELIGIBLE CLAIMANT."  A RESIDENT OF THE COMMONWEALTH FOR NO
     5  LESS THAN 90 DAYS, WHO IS 65 YEARS OF AGE AND OVER, WHOSE ANNUAL
     6  INCOME IS LESS THAN THE MAXIMUM ANNUAL INCOME AND WHO IS NOT
     7  OTHERWISE QUALIFIED FOR PUBLIC ASSISTANCE UNDER THE ACT OF JUNE
     8  13, 1967 (P.L.31, NO.21), KNOWN AS THE PUBLIC WELFARE CODE.
     9     "FDA."  THE UNITED STATES FOOD AND DRUG ADMINISTRATION OF THE
    10  PUBLIC HEALTH SERVICE OF THE DEPARTMENT OF HEALTH AND HUMAN
    11  SERVICES.
    12     "HCFA."  THE HEALTH CARE FINANCING ADMINISTRATION OF THE
    13  UNITED STATES.
    14     "INCOME."  ALL INCOME FROM WHATEVER SOURCE DERIVED,
    15  INCLUDING, BUT NOT LIMITED TO, SALARIES, WAGES, BONUSES,
    16  COMMISSIONS, INCOME FROM SELF-EMPLOYMENT, ALIMONY, SUPPORT
    17  MONEY, CASH PUBLIC ASSISTANCE AND RELIEF, THE GROSS AMOUNT OF
    18  ANY PENSIONS OR ANNUITIES, INCLUDING RAILROAD RETIREMENT
    19  BENEFITS, ALL BENEFITS RECEIVED UNDER THE FEDERAL SOCIAL
    20  SECURITY ACT (49 STAT. 620, 42 U.S.C. § 301 ET. SEQ.) (EXCEPT
    21  MEDICARE BENEFITS), ALL BENEFITS RECEIVED UNDER STATE
    22  UNEMPLOYMENT INSURANCE LAWS AND VETERANS' DISABILITY PAYMENTS,
    23  ALL INTEREST RECEIVED FROM THE FEDERAL GOVERNMENT OR ANY STATE
    24  GOVERNMENT, OR ANY INSTRUMENTALITY OR POLITICAL SUBDIVISION
    25  THEREOF, REALIZED CAPITAL GAINS, RENTALS, WORKMEN'S COMPENSATION
    26  AND THE GROSS AMOUNT OF LOSS OF TIME INSURANCE BENEFITS, LIFE
    27  INSURANCE BENEFITS AND PROCEEDS, EXCEPT THE FIRST $5,000 OF THE
    28  TOTAL OF DEATH BENEFITS PAYMENTS, AND GIFTS OF CASH OR PROPERTY,
    29  OTHER THAN TRANSFERS BY GIFT BETWEEN MEMBERS OF A HOUSEHOLD, IN
    30  EXCESS OF A TOTAL VALUE OF $300, BUT SHALL NOT INCLUDE SURPLUS
    19950H0544B4238                 - 26 -

     1  FOOD OR OTHER RELIEF IN KIND SUPPLIED BY A GOVERNMENT AGENCY OR
     2  PROPERTY TAX REBATE.
     3     "MAXIMUM ANNUAL INCOME."  FOR PACE ELIGIBILITY, THE TERM
     4  SHALL MEAN ANNUAL INCOME WHICH SHALL NOT EXCEED $14,000 IN THE
     5  CASE OF SINGLE PERSONS NOR $17,200 IN THE CASE OF THE COMBINED
     6  ANNUAL INCOME OF PERSONS MARRIED TO EACH OTHER. PERSONS MAY, IN
     7  REPORTING INCOME TO THE DEPARTMENT OF AGING, ROUND THE AMOUNT OF
     8  EACH SOURCE OF INCOME AND THE INCOME TOTAL TO THE NEAREST WHOLE
     9  DOLLAR, WHEREBY ANY AMOUNT WHICH IS LESS THAN 50¢ IS ELIMINATED.
    10     "PACE."  THE PHARMACEUTICAL ASSISTANCE CONTRACT FOR THE
    11  ELDERLY PROGRAM PROVIDED FOR IN THIS CHAPTER.
    12     "PACENET."  THE PHARMACEUTICAL ASSISTANCE CONTRACT FOR THE
    13  ELDERLY NEEDS ENHANCEMENT TIER PROVIDED FOR IN THIS CHAPTER.
    14     "PHARMACY."  A PHARMACY LICENSED BY THE COMMONWEALTH.
    15     "PRESCRIPTION DRUG."  ALL DRUGS REQUIRING A PRESCRIPTION IN
    16  THIS COMMONWEALTH, INSULIN, INSULIN SYRINGES AND INSULIN
    17  NEEDLES. EXPERIMENTAL DRUGS OR DRUGS PRESCRIBED FOR WRINKLE
    18  REMOVAL OR HAIR GROWTH ARE PROHIBITED.
    19     "PRIVATE CONTRACTOR."  A PERSON, PARTNERSHIP OR CORPORATE
    20  ENTITY WHO ENTERS INTO A CONTRACT WITH THE COMMONWEALTH TO
    21  PROVIDE SERVICES UNDER THE PROVISIONS OF THIS CHAPTER.
    22     "PROGRAM."  THE PHARMACEUTICAL ASSISTANCE CONTRACT FOR THE
    23  ELDERLY (PACE) AND THE PHARMACEUTICAL ASSISTANCE CONTRACT FOR
    24  THE ELDERLY NEEDS ENHANCEMENT TIER (PACENET) AS ESTABLISHED BY
    25  THIS CHAPTER, UNLESS OTHERWISE SPECIFIED.
    26     "PROVIDER."  A PHARMACY OR DISPENSING PHYSICIAN ENROLLED AS A
    27  PROVIDER IN THE PROGRAM.
    28  SECTION 503.  DETERMINATION OF ELIGIBILITY.
    29     THE DEPARTMENT SHALL ADOPT REGULATIONS RELATING TO THE
    30  DETERMINATION OF ELIGIBILITY OF PROSPECTIVE CLAIMANTS AND
    19950H0544B4238                 - 27 -

     1  PROVIDERS, INCLUDING DISPENSING PHYSICIANS, AND THE
     2  DETERMINATION AND ELIMINATION OF PROGRAM ABUSE. TO THIS END, THE
     3  DEPARTMENT SHALL ESTABLISH A COMPLIANCE UNIT STAFFED
     4  SUFFICIENTLY TO FULFILL THIS RESPONSIBILITY. THE DEPARTMENT
     5  SHALL HAVE THE POWER TO DECLARE INELIGIBLE ANY CLAIMANT OR
     6  PROVIDER WHO ABUSES OR MISUSES THE ESTABLISHED PRESCRIPTION
     7  PLAN. THE DEPARTMENT SHALL HAVE THE POWER TO INVESTIGATE CASES
     8  OF SUSPECTED PROVIDER OR RECIPIENT FRAUD.
     9  SECTION 504.  PHYSICIAN AND PHARMACY PARTICIPATION.
    10     ANY PHYSICIAN, PHARMACIST, PHARMACY OR CORPORATION OWNED IN
    11  WHOLE OR IN PART BY A PHYSICIAN OR PHARMACIST ENROLLED AS A
    12  PROVIDER IN THE PROGRAM, OR WHO HAS PRESCRIBED MEDICATION FOR A
    13  CLAIMANT IN THE PROGRAM, WHO IS PRECLUDED OR EXCLUDED FOR CAUSE
    14  FROM THE DEPARTMENT OF PUBLIC WELFARE'S MEDICAL ASSISTANCE
    15  PROGRAM SHALL BE PRECLUDED OR EXCLUDED FROM PARTICIPATION IN THE
    16  PROGRAM. NO PHYSICIAN PRECLUDED OR EXCLUDED FROM THE DEPARTMENT
    17  OF PUBLIC WELFARE'S MEDICAL ASSISTANCE PROGRAM SHALL HAVE CLAIMS
    18  RESULTING FROM PRESCRIPTIONS PAID FOR BY THE PROGRAM.
    19  SECTION 505.  DRUG UTILIZATION REVIEW SYSTEM.
    20     THE DEPARTMENT SHALL ENSURE THAT A STATE-OF-THE-ART
    21  THERAPEUTIC DRUG UTILIZATION REVIEW SYSTEM IS ESTABLISHED TO
    22  MONITOR AND CORRECT MISUTILIZATION OF DRUG THERAPIES.
    23  SECTION 506.  REDUCED ASSISTANCE.
    24     ANY ELIGIBLE CLAIMANT WHOSE PRESCRIPTION DRUG COSTS ARE
    25  COVERED IN PART BY ANY OTHER PLAN OF ASSISTANCE OR INSURANCE MAY
    26  BE REQUIRED TO RECEIVE REDUCED ASSISTANCE UNDER THE PROVISIONS
    27  OF THIS CHAPTER.
    28  SECTION 507.  REBATES FOR EXPENSES PROHIBITED.
    29     A SYSTEM OF REBATES OR REIMBURSEMENTS TO THE CLAIMANT FOR
    30  PRESCRIPTION DRUGS SHALL BE PROHIBITED.
    19950H0544B4238                 - 28 -

     1  SECTION 508.  REQUEST FOR PROPOSAL.
     2     (A)  GENERAL RULE.--THE DEPARTMENT SHALL PREPARE A REQUEST
     3  FOR PROPOSAL FOR THE PURPOSE OF PROVIDING PHARMACEUTICAL
     4  ASSISTANCE FOR THE ELDERLY WITHIN THIS COMMONWEALTH. UPON THE
     5  ADOPTION OF THE GENERAL FUND BUDGET, THE DEPARTMENT OF REVENUE
     6  SHALL BE AUTHORIZED TO TRANSMIT THE APPROPRIATED FUNDS IN THE
     7  STATE LOTTERY FUND TO THE STATE TREASURER TO BE DEPOSITED IN THE
     8  PHARMACEUTICAL ASSISTANCE CONTRACT FOR THE ELDERLY FUND. THIS
     9  FUND SHALL CONSIST OF APPROPRIATIONS AND INTEREST AND SHALL BE
    10  CREATED BY THE STATE TREASURER TO FUND THE OPERATIONS OF THE
    11  PROGRAM BY THE DEPARTMENT AND THE PRIVATE CONTRACTOR. FUNDS NOT
    12  EXPENDED IN THE FISCAL YEAR IN WHICH THEY WERE APPROPRIATED
    13  SHALL NOT LAPSE AND BE AVAILABLE FOR USE IN THE NEXT FISCAL
    14  YEAR.
    15     (B)  ADDITIONAL REQUESTS FOR PROPOSALS.--TO PROVIDE FOR THE
    16  CONTINUED OPERATION OF THE PROGRAM, THE DEPARTMENT SHALL
    17  PREPARE, AS NEEDED, REQUESTS FOR PROPOSALS, IN ADDITION TO THAT
    18  SET FORTH IN SUBSECTION (A), FOR THE PURPOSE OF PROVIDING
    19  PHARMACEUTICAL ASSISTANCE FOR THE ELDERLY WITHIN THIS
    20  COMMONWEALTH. A REQUEST FOR PROPOSAL SHALL REQUIRE POTENTIAL
    21  PRIVATE CONTRACTORS TO SUBMIT A PROPOSAL FOR A PERIOD OF TIME
    22  AND WITH MONETARY LIMITATIONS AS DETERMINED BY THE DEPARTMENT.
    23  UPON THE ENACTMENT OF AN APPROPRIATION FROM THE STATE LOTTERY
    24  FUND, THE DEPARTMENT OF REVENUE SHALL BE AUTHORIZED TO TRANSMIT
    25  THE APPROPRIATED AMOUNT TO THE STATE TREASURER TO BE DEPOSITED
    26  IN THE PHARMACEUTICAL ASSISTANCE CONTRACT FOR THE ELDERLY FUND.
    27  FUNDS NOT EXPENDED IN THE FISCAL YEAR IN WHICH THEY WERE
    28  APPROPRIATED SHALL NOT LAPSE AND SHALL BE AVAILABLE FOR USE IN
    29  THE NEXT FISCAL YEAR.
    30  SECTION 509.  PROGRAM GENERALLY.
    19950H0544B4238                 - 29 -

     1     THE PROGRAM SHALL INCLUDE THE FOLLOWING:
     2         (1)  PARTICIPATING PHARMACIES SHALL BE PAID WITHIN 21
     3     DAYS OF THE CONTRACTING FIRM RECEIVING THE APPROPRIATE
     4     SUBSTANTIATION OF THE TRANSACTION. PHARMACIES SHALL BE
     5     ENTITLED TO INTEREST FOR PAYMENT NOT MADE WITHIN THE 21-DAY
     6     PERIOD AT A RATE APPROVED BY THE BOARD.
     7         (2)  COLLECTION OF THE COPAYMENT BY PHARMACIES SHALL BE
     8     MANDATORY.
     9         (3)  SENIOR CITIZENS PARTICIPATING IN THE PROGRAM ARE NOT
    10     REQUIRED TO MAINTAIN RECORDS OF EACH TRANSACTION.
    11         (4)  A SYSTEM OF REBATES OR REIMBURSEMENTS TO ELIGIBLE
    12     CLAIMANTS FOR PHARMACEUTICAL EXPENSES SHALL BE PROHIBITED.
    13         (5)  PACE SHALL INCLUDE A PARTICIPANT COPAYMENT SCHEDULE
    14     FOR EACH PRESCRIPTION. THE COPAYMENT MAY INCREASE OR DECREASE
    15     ON AN ANNUAL BASIS BY THE AVERAGE PERCENT CHANGE OF
    16     INGREDIENT COSTS FOR ALL PRESCRIPTION DRUGS PLUS A
    17     DIFFERENTIAL TO RAISE THE COPAYMENT TO THE NEXT HIGHEST 25¢
    18     INCREMENT. IN ADDITION, THE DEPARTMENT MAY APPROVE A REQUEST
    19     FOR INCREASE OR DECREASE IN THE LEVEL OF COPAYMENT BASED UPON
    20     THE FINANCIAL EXPERIENCE AND PROJECTIONS OF PACE AND AFTER
    21     CONSULTATION WITH THE BOARD. THE DEPARTMENT IS PROHIBITED
    22     FROM APPROVING ADJUSTMENTS TO THE COPAYMENT ON MORE THAN AN
    23     ANNUAL BASIS.
    24         (6)  THE PROGRAM SHALL CONSIST OF PAYMENTS TO PHARMACIES
    25     ON BEHALF OF ELIGIBLE CLAIMANTS FOR 90% OF THE AVERAGE
    26     WHOLESALE COSTS OF PRESCRIPTION DRUGS WHICH EXCEED THE
    27     COPAYMENT, PLUS A DISPENSING FEE OF AT LEAST $3.50 OR THE
    28     DISPENSING FEE ESTABLISHED BY THE DEPARTMENT BY REGULATION,
    29     WHICHEVER IS GREATER.
    30         (7)  IN NO CASE SHALL THE COMMONWEALTH OR ANY PERSON
    19950H0544B4238                 - 30 -

     1     ENROLLED IN THE PROGRAM BE CHARGED MORE THAN THE PRICE OF THE
     2     DRUG AT THE PARTICULAR PHARMACY ON THE DATE OF THE SALE.
     3  SECTION 510.  GENERIC DRUGS.
     4     (A)  IN GENERAL.--NOTWITHSTANDING ANY OTHER STATUTE OR
     5  REGULATION, IF AN A-RATED GENERIC THERAPEUTICALLY EQUIVALENT
     6  DRUG IS AVAILABLE FOR DISPENSING TO A CLAIMANT, THE PROVIDER
     7  SHALL DISPENSE THE A-RATED GENERIC THERAPEUTICALLY EQUIVALENT
     8  DRUG TO THE CLAIMANT. THE DEPARTMENT SHALL NOT REIMBURSE
     9  PROVIDERS FOR BRAND NAME PRODUCTS EXCEPT IN THE FOLLOWING
    10  CIRCUMSTANCES:
    11         (1)  THERE IS NO A-RATED GENERIC THERAPEUTICALLY
    12     EQUIVALENT DRUG AVAILABLE ON THE MARKET. THIS SUBPARAGRAPH
    13     DOES NOT APPLY TO THE LACK OF AVAILABILITY OF AN A-RATED
    14     GENERIC THERAPEUTICALLY EQUIVALENT DRUG IN THE PROVIDING
    15     PHARMACY, UNLESS IT CAN BE SHOWN TO THE DEPARTMENT THAT THE
    16     PROVIDER MADE REASONABLE ATTEMPTS TO OBTAIN THE A-RATED
    17     GENERIC THERAPEUTICALLY EQUIVALENT DRUG OR THAT THERE WAS AN
    18     UNFORESEEABLE DEMAND AND DEPLETION OF THE SUPPLY OF THE A-
    19     RATED GENERIC THERAPEUTICALLY EQUIVALENT DRUG. IN EITHER
    20     CASE, THE DEPARTMENT SHALL REIMBURSE THE PROVIDER FOR 90% OF
    21     THE AVERAGE WHOLESALE COST PLUS A DISPENSING FEE BASED ON THE
    22     LEAST EXPENSIVE A-RATED GENERIC THERAPEUTICALLY EQUIVALENT
    23     DRUG FOR THE BRAND DRUG DISPENSED.
    24         (2)  AN A-RATED GENERIC THERAPEUTICALLY EQUIVALENT DRUG
    25     IS DEEMED BY THE DEPARTMENT, IN CONSULTATION WITH A
    26     UTILIZATION REVIEW COMMITTEE, TO HAVE TOO NARROW A
    27     THERAPEUTIC INDEX FOR SAFE AND EFFECTIVE DISPENSING IN THE
    28     COMMUNITY SETTING. THE DEPARTMENT SHALL NOTIFY PROVIDING
    29     PHARMACIES OF A-RATED GENERIC THERAPEUTICALLY EQUIVALENT
    30     DRUGS THAT ARE IDENTIFIED PURSUANT TO THIS SUBPARAGRAPH ON A
    19950H0544B4238                 - 31 -

     1     REGULAR BASIS.
     2         (3)  THE DEPARTMENT OF HEALTH HAS DETERMINED THAT A DRUG
     3     SHALL NOT BE RECOGNIZED AS AN A-RATED GENERIC THERAPEUTICALLY
     4     EQUIVALENT DRUG FOR PURPOSE OF SUBSTITUTION UNDER SECTION
     5     5(B) OF THE ACT OF NOVEMBER 24, 1976 (P.L.1163, NO.259),
     6     REFERRED TO AS THE GENERIC EQUIVALENT DRUG LAW.
     7         (4)  AT THE TIME OF DISPENSING, THE PROVIDER HAS A
     8     PRESCRIPTION ON WHICH THE BRAND NAME DRUG DISPENSED IS BILLED
     9     TO THE PROGRAM BY THE PROVIDER AT A USUAL AND CUSTOMARY
    10     CHARGE WHICH IS EQUAL TO OR LESS THAN THE LEAST EXPENSIVE
    11     USUAL AND CUSTOMARY CHARGE OF ANY A-RATED GENERIC
    12     THERAPEUTICALLY EQUIVALENT DRUG REASONABLY AVAILABLE ON THE
    13     MARKET TO THE PROVIDER.
    14     (B)  GENERIC NOT ACCEPTED.--IF A CLAIMANT CHOOSES NOT TO
    15  ACCEPT THE A-RATED GENERIC THERAPEUTICALLY EQUIVALENT DRUG
    16  REQUIRED BY SUBSECTION (A), THE CLAIMANT SHALL BE LIABLE FOR THE
    17  COPAYMENT AND 70% OF THE AVERAGE WHOLESALE COST OF THE BRAND
    18  NAME DRUG.
    19     (C)  GENERIC DRUGS NOT DEEMED INCORRECT SUBSTITUTION.--THE
    20  DISPENSING OF AN A-RATED GENERIC THERAPEUTICALLY EQUIVALENT DRUG
    21  IN ACCORDANCE WITH THIS CHAPTER SHALL NOT BE DEEMED INCORRECT
    22  SUBSTITUTION UNDER SECTION 6(A) OF THE ACT OF NOVEMBER 24, 1976
    23  (P.L.1163, NO.259), REFERRED TO AS THE GENERIC EQUIVALENT DRUG
    24  LAW.
    25     (D)  MEDICAL EXCEPTION.--A MEDICAL EXCEPTION PROCESS SHALL BE
    26  ESTABLISHED BY THE DEPARTMENT, WHICH SHALL BE PUBLISHED AS A
    27  NOTICE IN THE PENNSYLVANIA BULLETIN AND DISTRIBUTED TO PROVIDERS
    28  AND RECIPIENTS IN THE PROGRAM.
    29  SECTION 511.  SUPPLY.
    30     PRESCRIPTION BENEFITS FOR ANY SINGLE PRESCRIPTION SHALL BE
    19950H0544B4238                 - 32 -

     1  LIMITED TO A 30-DAY SUPPLY OF THE PRESCRIPTION DRUG OR 100
     2  UNITS, WHICHEVER IS LESS, EXCEPT THAT, IN THE CASE OF DIAGNOSIS
     3  FOR ACUTE CONDITIONS, THE LIMITATION SHALL BE A 15-DAY SUPPLY.
     4  THIS LIMITATION SHALL NOT APPLY TO TOPICAL OINTMENTS OR GELS
     5  THAT ARE NOT AVAILABLE IN CONTAINERS WHICH MEET THE SIZE AND
     6  SUPPLY RESTRICTIONS SET FORTH IN THIS SECTION.
     7  SECTION 512.  RESTRICTED FORMULARY.
     8     THE DEPARTMENT MAY ESTABLISH A RESTRICTED FORMULARY OF THE
     9  DRUGS WHICH WILL NOT BE REIMBURSED BY THE PROGRAM. THIS
    10  FORMULARY SHALL INCLUDE ONLY EXPERIMENTAL DRUGS AND DRUGS ON THE
    11  DRUG EFFICACY STUDY IMPLEMENTATION LIST PREPARED BY THE HEALTH
    12  CARE FINANCE ADMINISTRATION. A MEDICAL EXCEPTION MAY BE
    13  PERMITTED BY THE DEPARTMENT FOR REIMBURSEMENT OF A DRUG ON THE
    14  DRUG EFFICACY STUDY IMPLEMENTATION LIST UPON DECLARATION OF ITS
    15  NECESSITY ON THE PRESCRIPTION BY THE TREATING PHYSICIAN; EXCEPT
    16  THAT, FOR DESI DRUGS FOR WHICH THE FDA HAS ISSUED A NOTICE FOR
    17  OPPORTUNITY HEARING (NOOH) FOR THE PURPOSE OF WITHDRAWING THE
    18  NEW DRUG APPLICATION APPROVED FOR THAT DRUG, REIMBURSEMENT
    19  COVERAGE SHALL BE DISCONTINUED UNDER THE PROVISIONS OF THIS
    20  CHAPTER.
    21  SECTION 513.  MAIL ORDER SYSTEM.
    22     THE DEPARTMENT MAY NOT ENTER INTO A CONTRACT WITH A PRIVATE
    23  CONTRACTOR FOR AN EXCLUSIVE MAIL-ORDER SYSTEM FOR THE DELIVERY
    24  OF PRESCRIPTION DRUGS UNDER THIS PROGRAM. ONLY MAIL-ORDER
    25  PHARMACY SERVICES PROVIDED BY PHARMACIES WHICH ARE LICENSED BY
    26  THE COMMONWEALTH AND WHICH HAVE THEIR PRINCIPAL PLACE OF
    27  BUSINESS WITHIN THIS COMMONWEALTH MAY PARTICIPATE AS PROVIDERS
    28  UNDER THE PROGRAM. THE DEPARTMENT SHALL DEVELOP AND PROMULGATE
    29  SPECIFIC REGULATIONS GOVERNING THE PRACTICE OF MAIL-ORDER
    30  PHARMACY AND OTHER ENROLLED PROVIDERS TO INCLUDE THE FOLLOWING
    19950H0544B4238                 - 33 -

     1  MINIMUM STANDARDS OF PRACTICE TO ENSURE THE HEALTH, SAFETY AND
     2  WELFARE OF PROGRAM PARTICIPANTS:
     3         (1)  THE APPROPRIATE METHOD OR METHODS BY WHICH SUCH
     4     PHARMACIES SHALL VERIFY THE IDENTITY OF THE PROGRAM RECIPIENT
     5     AND THE AUTHENTICITY OF PRESCRIPTIONS RECEIVED.
     6         (2)  THE APPROPRIATE METHOD OR METHODS BY WHICH SUCH
     7     PHARMACIES SHALL MAIL OR DELIVER PRESCRIPTION DRUGS TO
     8     PROGRAM RECIPIENTS ENSURING, TO THE MAXIMUM EXTENT POSSIBLE,
     9     THAT THE INTENDED PROGRAM RECIPIENT IS THE ACTUAL ULTIMATE
    10     RECIPIENT OF ANY PRESCRIPTION DISPENSED BY SUCH PHARMACIES.
    11         (3)  THE APPROPRIATE METHOD OR METHODS BY WHICH SUCH
    12     PHARMACIES SHALL COMMUNICATE WITH PROGRAM PARTICIPANTS IN
    13     EMERGENCY SITUATIONS.
    14  SECTION 514.  INDICATION OF PRICE.
    15     THE RETAIL PRICE OF THE PRESCRIPTION SHALL BE INDICATED ON
    16  THE LABEL OF THE PRESCRIPTION CONTAINER OR FURNISHED BY SEPARATE
    17  RECEIPT.
    18  SECTION 515.  REIMBURSEMENT.
    19     FOR-PROFIT THIRD PARTY INSURERS AND NOT-FOR-PROFIT
    20  PRESCRIPTION PLANS SHALL BE RESPONSIBLE FOR ANY PAYMENTS MADE TO
    21  A PROVIDING PHARMACY ON BEHALF OF A CLAIMANT COVERED BY SUCH A
    22  THIRD PARTY.
    23  SECTION 516.  NONLIABILITY.
    24     (A)  PERSONS RENDERING SERVICE.--ANY PERSON RENDERING SERVICE
    25  AS A MEMBER OF A UTILIZATION REVIEW COMMITTEE FOR THIS PROGRAM
    26  SHALL NOT BE LIABLE FOR ANY CIVIL DAMAGES AS A RESULT OF ANY
    27  ACTS OR OMISSIONS IN RENDERING THE SERVICE AS A MEMBER OF ANY
    28  SUCH COMMITTEE EXCEPT ANY ACTS OR OMISSIONS INTENTIONALLY
    29  DESIGNED TO HARM OR ANY GROSSLY NEGLIGENT ACTS OR OMISSIONS
    30  WHICH RESULT IN HARM TO THE PERSON RECEIVING SUCH SERVICE.
    19950H0544B4238                 - 34 -

     1     (B)  OFFICER AND EMPLOYEES OF DEPARTMENT.--ANY OFFICER OR
     2  EMPLOYEE OF THE DEPARTMENT RENDERING SERVICE AS A MEMBER OF A
     3  UTILIZATION REVIEW COMMITTEE FOR THIS PROGRAM SHALL NOT BE
     4  LIABLE FOR ANY CIVIL DAMAGES AS A RESULT OF ANY ACTS OR
     5  OMISSIONS IN RENDERING THE SERVICE AS A MEMBER OF ANY SUCH
     6  COMMITTEE OR AS A RESULT OF ANY DECISION OR ACTION IN CONNECTION
     7  WITH THE PROGRAM EXCEPT ANY ACTS OR OMISSIONS INTENTIONALLY
     8  DESIGNED TO HARM OR ANY GROSSLY NEGLIGENT ACTS OR OMISSIONS
     9  WHICH RESULT IN HARM TO THE PERSON RECEIVING SUCH SERVICE.
    10  SECTION 517.  INCOME VERIFICATION.
    11     (A)  PROCEDURE.--THE DEPARTMENT SHALL ANNUALLY VERIFY THE
    12  INCOME OF ELIGIBLE CLAIMANTS. THE DEPARTMENT SHALL VERIFY THE
    13  INCOME OF ELIGIBLE CLAIMANTS BY REQUIRING INCOME DOCUMENTATION
    14  FROM THE CLAIMANTS. AN APPLICATION FOR BENEFITS UNDER THIS
    15  CHAPTER SHALL CONSTITUTE A WAIVER TO THE DEPARTMENT OF ALL
    16  RELEVANT CONFIDENTIALITY REQUIREMENTS RELATING TO THE CLAIMANT'S
    17  PENNSYLVANIA STATE INCOME TAX INFORMATION IN THE POSSESSION OF
    18  THE DEPARTMENT OF REVENUE. THE DEPARTMENT OF REVENUE SHALL
    19  PROVIDE THE DEPARTMENT WITH THE NECESSARY INCOME INFORMATION
    20  SHOWN ON THE CLAIMANT'S PENNSYLVANIA STATE INCOME TAX RETURN
    21  SOLELY FOR INCOME VERIFICATION PURPOSES.
    22     (B)  INFORMATION CONFIDENTIAL.--IT SHALL BE UNLAWFUL FOR ANY
    23  OFFICER, AGENT OR EMPLOYEE OF THE DEPARTMENT TO DIVULGE OR MAKE
    24  KNOWN IN ANY MANNER WHATSOEVER ANY INFORMATION GAINED THROUGH
    25  ACCESS TO THE DEPARTMENT OF REVENUE INFORMATION EXCEPT FOR
    26  OFFICIAL INCOME VERIFICATION PURPOSES UNDER THIS CHAPTER.
    27     (C)  PENALTY.--A PERSON WHO VIOLATES THIS ACT COMMITS A
    28  MISDEMEANOR AND SHALL, UPON CONVICTION, BE SENTENCED TO PAY A
    29  FINE OF NOT MORE THAN $1,000 OR TO IMPRISONMENT FOR NOT MORE
    30  THAN ONE YEAR, OR BOTH, TOGETHER WITH THE COST OF PROSECUTION,
    19950H0544B4238                 - 35 -

     1  AND IF THE OFFENDER IS AN OFFICER OR EMPLOYEE OF THE
     2  COMMONWEALTH, HE SHALL BE DISMISSED FROM OFFICE OR DISCHARGED
     3  FROM EMPLOYMENT.
     4     (D)  COORDINATION WITH DEPARTMENT OF PUBLIC WELFARE.--TO THE
     5  EXTENT POSSIBLE, THE DEPARTMENT AND THE DEPARTMENT OF PUBLIC
     6  WELFARE SHALL COORDINATE EFFORTS TO FACILITATE THE APPLICATION
     7  AND ENROLLMENT OF ELIGIBLE OLDER PEOPLE IN THE MEDICAID HEALTHY
     8  HORIZONS PROGRAM BY PROCESSING THESE APPLICATIONS AT SENIOR
     9  CITIZENS CENTERS AND OTHER APPROPRIATE FACILITIES PROVIDING
    10  SERVICES TO THE ELDERLY.
    11  SECTION 518.  CONTRACT.
    12     THE DEPARTMENT IS AUTHORIZED TO ENTER INTO A CONTRACT
    13  PROVIDING FOR PRESCRIPTION DRUGS TO ELIGIBLE PERSONS PURSUANT TO
    14  THIS CHAPTER. THE DEPARTMENT SHALL SELECT A PROPOSAL THAT
    15  INCLUDES, BUT IS NOT LIMITED TO, THE CRITERIA SET FORTH IN THIS
    16  CHAPTER.
    17  SECTION 519.  THE PHARMACEUTICAL ASSISTANCE CONTRACT FOR THE
    18                 ELDERLY NEEDS ENHANCEMENT TIER.
    19     (A)  ESTABLISHMENT.--THERE IS HEREBY ESTABLISHED WITHIN THE
    20  DEPARTMENT A PROGRAM TO BE KNOWN AS THE PHARMACEUTICAL
    21  ASSISTANCE CONTRACT FOR THE ELDERLY NEEDS ENHANCEMENT TIER
    22  (PACENET).
    23     (B)  PACENET ELIGIBILITY.--A CLAIMANT WITH AN ANNUAL INCOME
    24  OF NOT LESS THAN $14,000 AND NOT MORE THAN $16,000 IN THE CASE
    25  OF A SINGLE PERSON AND OF NOT LESS THAN $17,200 AND NOT MORE
    26  THAN $19,200 IN THE CASE OF THE COMBINED INCOME OF PERSONS
    27  MARRIED TO EACH OTHER SHALL BE ELIGIBLE FOR ENHANCED
    28  PHARMACEUTICAL ASSISTANCE UNDER THIS SECTION. A PERSON MAY, IN
    29  REPORTING INCOME TO THE DEPARTMENT, ROUND THE AMOUNT OF EACH
    30  SOURCE OF INCOME AND THE INCOME TOTAL TO THE NEAREST WHOLE
    19950H0544B4238                 - 36 -

     1  DOLLAR, WHEREBY ANY AMOUNT WHICH IS LESS THAN 50¢ IS ELIMINATED.
     2     (C)  DEDUCTIBLE.--UPON ENROLLMENT IN PACENET, ELIGIBLE
     3  CLAIMANTS IN THE INCOME RANGES SET FORTH IN SUBSECTION (B) SHALL
     4  BE REQUIRED TO MEET AN ANNUAL DEDUCTIBLE IN UNREIMBURSED
     5  PRESCRIPTION DRUG EXPENSES OF $500 PER PERSON. TO QUALIFY FOR
     6  THE DEDUCTIBLE SET FORTH IN THIS SUBSECTION THE PRESCRIPTION
     7  DRUG MUST BE PURCHASED FOR THE USE OF THE ELIGIBLE CLAIMANT FROM
     8  A PROVIDER AS DEFINED IN THIS CHAPTER. THE DEPARTMENT, AFTER
     9  CONSULTATION WITH THE BOARD, MAY APPROVE AN ADJUSTMENT IN THE
    10  DEDUCTIBLE ON AN ANNUAL BASIS.
    11     (D)  COPAYMENT.--FOR ELIGIBLE CLAIMANTS UNDER THIS SECTION,
    12  THE COPAYMENT SCHEDULE, WHICH MAY BE ADJUSTED BY THE DEPARTMENT
    13  ON AN ANNUAL BASIS AFTER CONSULTATION WITH THE BOARD, SHALL BE:
    14             (I)  EIGHT DOLLARS FOR NONINNOVATOR MULTIPLE SOURCE
    15         DRUGS AS DEFINED IN SECTION 702; OR
    16             (II)  FIFTEEN DOLLARS FOR SINGLE-SOURCE DRUGS AND
    17         INNOVATOR MULTIPLE-SOURCE DRUGS AS DEFINED IN SECTION
    18         702.
    19  SECTION 520.  BOARD.
    20     (A)  ESTABLISHMENT.--THE PHARMACEUTICAL ASSISTANCE REVIEW
    21  BOARD IS CONTINUED TO ENSURE THAT THE PROGRAM IS PROVIDING AND
    22  CONTINUES TO PROVIDE THE ASSISTANCE INTENDED IN A FISCALLY
    23  RESPONSIBLE MANNER WITHOUT EXCESSIVELY HAMPERING THE
    24  PHARMACEUTICAL INDUSTRY.
    25     (B)  COMPOSITION.--THE BOARD SHALL BE COMPRISED OF THE
    26  FOLLOWING EIGHT PERSONS:
    27         (1)  THE SECRETARY OF AGING, WHO SHALL SERVE AS ITS
    28     CHAIRMAN.
    29         (2)  THE SECRETARY OF REVENUE.
    30         (3)  THE SECRETARY OF HEALTH.
    19950H0544B4238                 - 37 -

     1         (4)  FIVE PUBLIC MEMBERS, ONE APPOINTED BY THE PRESIDENT
     2     PRO TEMPORE OF THE SENATE, ONE APPOINTED BY THE MINORITY
     3     LEADER OF THE SENATE, ONE APPOINTED BY THE SPEAKER OF THE
     4     HOUSE OF REPRESENTATIVES, ONE APPOINTED BY THE MINORITY
     5     LEADER OF THE HOUSE OF REPRESENTATIVES AND ONE APPOINTED BY
     6     THE GOVERNOR. THOSE APPOINTED BY THE LEGISLATIVE OFFICERS
     7     SHALL INCLUDE TWO SENIOR CITIZENS, WHO HAVE NOT BEEN A PART
     8     OF THE PHARMACEUTICAL INDUSTRY, TO SERVE AS CONSUMER
     9     ADVOCATES AND TWO REPRESENTATIVES OF THE PHARMACEUTICAL
    10     INDUSTRY, AT LEAST ONE OF WHOM IS A PRACTICING PENNSYLVANIA
    11     PHARMACIST. THE INDIVIDUAL APPOINTED BY THE GOVERNOR MUST BE
    12     A PHYSICIAN. A PUBLIC MEMBER WHO MISSES TWO CONSECUTIVE
    13     MEETINGS WITHOUT GOOD CAUSE ACCEPTABLE TO THE CHAIRMAN SHALL
    14     BE REPLACED BY THE APPOINTING AUTHORITY.
    15     (C)  REVIEW.--USING THE ANNUAL REPORT SUBMITTED BY THE
    16  DEPARTMENT PURSUANT TO SECTION 2102 AND OTHER APPROPRIATE DATA
    17  SOURCES, THE BOARD SHALL CONDUCT AN ANNUAL REVIEW. THE BOARD
    18  SHALL DEVELOP RECOMMENDATIONS CONCERNING ANY CHANGES IN THE
    19  LEVEL OF COPAYMENT, DEDUCTIBLE OR IN THE LEVEL OF FEES PAID TO
    20  PARTICIPATING PHARMACISTS. THE BOARD SHALL REVIEW THE
    21  DEPARTMENT'S THERAPEUTIC DRUG UTILIZATION REVIEW PROGRAM ON AN
    22  ONGOING BASIS. THE BOARD MAY ALSO RECOMMEND OTHER CHANGES IN THE
    23  STRUCTURE OF THE PROGRAM AND DIRECT THE DEPARTMENT TO ENTER INTO
    24  DISCUSSIONS WITH THE PRIVATE CONTRACTOR CONCERNING AMENDMENTS TO
    25  THE CONTRACT, OR THE DEPARTMENT MAY ENTER INTO SUCH DISCUSSION
    26  IF IT DEEMS NECESSARY. THE COPAYMENT OR DEDUCTIBLE SCHEDULE
    27  SHALL ONLY BE ADJUSTED ON AN ANNUAL BASIS.
    28     (D)  MEETINGS.--THE BOARD SHALL MEET AT LEAST TWO TIMES PER
    29  YEAR.
    30  SECTION 521.  PENALTIES.
    19950H0544B4238                 - 38 -

     1     (A)  PROHIBITED ACTS.--IT SHALL BE UNLAWFUL FOR ANY PERSON TO
     2  SUBMIT A FALSE OR FRAUDULENT CLAIM OR APPLICATION UNDER THIS
     3  CHAPTER, INCLUDING, BUT NOT LIMITED TO:
     4         (1)  AIDING OR ABETTING ANOTHER IN THE SUBMISSION OF A
     5     FALSE OR FRAUDULENT CLAIM OR APPLICATION;
     6         (2)  RECEIVING BENEFITS OR REIMBURSEMENT UNDER A PRIVATE,
     7     FEDERAL OR STATE PROGRAM FOR PRESCRIPTION ASSISTANCE AND
     8     CLAIMING OR RECEIVING DUPLICATIVE BENEFITS HEREUNDER;
     9         (3)  SOLICITING, RECEIVING, OFFERING OR PAYING ANY
    10     KICKBACK, BRIBE OR REBATE, IN CASH OR IN KIND, FROM OR TO ANY
    11     PERSON IN CONNECTION WITH THE FURNISHING OF SERVICES UNDER
    12     THIS CHAPTER;
    13         (4)  ENGAGING IN A PATTERN OF SUBMITTING CLAIMS THAT
    14     REPEATEDLY USES INCORRECT NATIONAL DRUG CODE NUMBERS FOR THE
    15     PURPOSE OF OBTAINING WRONGFUL ENHANCED REIMBURSEMENT; OR
    16         (5)  OTHERWISE VIOLATING ANY PROVISION OF THIS CHAPTER.
    17     (B)  CIVIL PENALTY.--IN ADDITION TO ANY APPROPRIATE CRIMINAL
    18  PENALTY FOR PROHIBITED ACTS UNDER THIS CHAPTER WHETHER OR NOT
    19  THAT ACT CONSTITUTES A CRIME UNDER 18 PA.C.S. (RELATING TO
    20  CRIMES AND OFFENSES), A PROVIDER WHO VIOLATES THIS SECTION MAY
    21  BE LIABLE FOR A CIVIL PENALTY IN AN AMOUNT NOT LESS THAN $500
    22  AND NOT MORE THAN $10,000 FOR EACH VIOLATION OF THIS ACT WHICH
    23  SHALL BE COLLECTED BY THE DEPARTMENT. EACH VIOLATION CONSTITUTES
    24  A SEPARATE OFFENSE. IF THE DEPARTMENT COLLECTS THREE OR MORE
    25  CIVIL PENALTIES AGAINST THE SAME PROVIDER, THE PROVIDER SHALL BE
    26  INELIGIBLE TO PARTICIPATE IN EITHER PACE OR PACENET FOR A PERIOD
    27  OF ONE YEAR. IF MORE THAN THREE CIVIL PENALTIES ARE COLLECTED
    28  FROM ANY PROVIDER, THE DEPARTMENT MAY DETERMINE THAT THE
    29  PROVIDER IS PERMANENTLY INELIGIBLE TO PARTICIPATE IN PACE OR
    30  PACENET.
    19950H0544B4238                 - 39 -

     1     (C)  SUSPENSION OF LICENSE.--THE LICENSE OF ANY PROVIDER WHO
     2  HAS BEEN FOUND GUILTY UNDER THIS CHAPTER SHALL BE SUSPENDED FOR
     3  A PERIOD OF ONE YEAR. THE LICENSE OF ANY PROVIDER WHO HAS
     4  COMMITTED THREE OR MORE VIOLATIONS OF THIS CHAPTER MAY BE
     5  SUSPENDED FOR A PERIOD OF ONE YEAR.
     6     (D)  REPAYMENT OF GAIN.--ANY PROVIDER, RECIPIENT OR OTHER
     7  PERSON WHO IS FOUND GUILTY OF A CRIME FOR VIOLATING THIS CHAPTER
     8  SHALL REPAY THREE TIMES THE VALUE OF THE MATERIAL GAIN RECEIVED.
     9  IN ADDITION TO THE CIVIL PENALTY AUTHORIZED PURSUANT TO
    10  SUBSECTION (B), THE DEPARTMENT MAY REQUIRE THE PROVIDER,
    11  RECIPIENT OR OTHER PERSON TO REPAY UP TO THREE TIMES THE VALUE
    12  OF ANY MATERIAL GAIN TO PACE OR PACENET.
    13  SECTION 522.  PRESCRIPTION DRUG EDUCATION PROGRAM.
    14     THE DEPARTMENT, IN COOPERATION WITH THE DEPARTMENT OF HEALTH,
    15  SHALL DEVELOP AND IMPLEMENT A STATEWIDE PRESCRIPTION DRUG
    16  EDUCATION PROGRAM DESIGNED TO INFORM OLDER ADULTS OF THE DANGERS
    17  OF PRESCRIPTION DRUG ABUSE AND MISUSE. THE PRESCRIPTION DRUG
    18  EDUCATION PROGRAM SHALL INCLUDE, BUT NOT BE LIMITED TO,
    19  INFORMATION CONCERNING THE FOLLOWING:
    20         (1)  THE HAZARDS OF PRESCRIPTION DRUG OVERDOSE.
    21         (2)  THE POTENTIAL DANGERS OF MIXING PRESCRIPTION DRUGS.
    22         (3)  THE DANGER OF RETAINING UNUSED PRESCRIPTION DRUGS
    23     AFTER THE NEED TO TAKE THEM NO LONGER EXISTS.
    24         (4)  THE NECESSITY TO CAREFULLY QUESTION PHYSICIANS AND
    25     PHARMACISTS CONCERNING THE EFFECTS OF TAKING PRESCRIPTION
    26     DRUGS, INCLUDING THE DIFFERENCES BETWEEN BRAND NAME DRUGS AND
    27     GENERICALLY EQUIVALENT DRUGS.
    28         (5)  THE ADVISABILITY OF MAINTAINING A PRESCRIPTION DRUG
    29     PROFILE OR OTHER RECORD OF PRESCRIPTION DRUG DOSAGE AND
    30     FREQUENCY OF DOSAGE.
    19950H0544B4238                 - 40 -

     1         (6)  THE DESIRABILITY OF ADVISING FAMILY MEMBERS OF THE
     2     TYPES AND PROPER DOSAGE OF PRESCRIPTION DRUGS WHICH ARE BEING
     3     TAKEN.
     4         (7)  THE DANGERS OF TAKING PRESCRIPTION DRUGS IN EXCESS
     5     OF PRESCRIBED DOSAGES.
     6         (8)  THE NEED TO OBTAIN COMPLETE, DETAILED DIRECTIONS
     7     FROM THE PHYSICIAN OR PHARMACIST CONCERNING THE TIME PERIOD A
     8     PRESCRIPTION DRUG SHOULD BE TAKEN.
     9                             CHAPTER 7
    10                 PRUDENT PHARMACEUTICAL PURCHASING
    11  SECTION 701.  DECLARATION OF POLICY.
    12     THE GENERAL ASSEMBLY FINDS AND DECLARES AS FOLLOWS:
    13         (1)  THE COMMONWEALTH, THROUGH ASSISTANCE PROGRAMS
    14     ENACTED FOR THE BENEFIT OF ITS CITIZENS, IS THE LARGEST
    15     SINGLE PAYOR OF PRESCRIPTION MEDICATIONS IN PENNSYLVANIA.
    16         (2)  IN ORDER TO ENSURE THAT THE COMMONWEALTH, IN
    17     EXPENDING MONEY ON BEHALF OF ITS CITIZENS, IS NOT UNDULY
    18     HARMED BY BEING REQUIRED TO PAY A PRICE FOR PHARMACEUTICAL
    19     PRODUCTS PURCHASED FROM MANUFACTURERS IN EXCESS OF THAT
    20     ESTABLISHED FOR OTHER PURCHASERS AND REIMBURSERS OF THESE
    21     PRODUCTS AND TO ENSURE THAT THE COMMONWEALTH CAN EFFICIENTLY
    22     AND PRUDENTLY EXPEND ITS MONEY AND MAXIMIZE ITS ABILITY TO
    23     PROVIDE FOR THE HEALTH AND WELFARE OF AS MANY OF ITS NEEDY
    24     CITIZENS AS POSSIBLE, IT IS REASONABLE, NECESSARY AND IN THE
    25     PUBLIC INTEREST TO REQUIRE THAT PHARMACEUTICAL MANUFACTURERS
    26     OFFER A DISCOUNT TO THE COMMONWEALTH FOR PHARMACEUTICAL
    27     PRODUCTS PURCHASED OR REIMBURSED THROUGH STATE AGENCIES.
    28         (3)  IT IS IN THE PUBLIC INTEREST FOR PHARMACEUTICAL
    29     MANUFACTURERS TO PROVIDE THE COMMONWEALTH WITH DATA RELATING
    30     TO THE PRICE OF PHARMACEUTICAL PRODUCTS SOLD BY THE
    19950H0544B4238                 - 41 -

     1     MANUFACTURER TO PUBLIC BODIES, HOSPITALS, FOR-PROFIT OR
     2     NONPROFIT ORGANIZATIONS, OTHER MANUFACTURERS OR WHOLESALERS
     3     DOING BUSINESS IN THIS COMMONWEALTH IN ORDER TO ENSURE THAT
     4     THE COMMONWEALTH CAN DETERMINE THAT IT IS BEING PROVIDED WITH
     5     THE BEST PRICES OFFERED BY THE MANUFACTURER.
     6         (4)  ON A NATIONAL LEVEL, THERE HAS BEEN A RECOGNITION
     7     THAT THE NEED FOR DISCOUNTS TO STATE MEDICAID AGENCIES, WHICH
     8     REIMBURSE FOR A HIGH VOLUME OF PHARMACEUTICAL PRODUCTS,
     9     EXISTS.
    10         (5)  ON A STATE LEVEL, THE GENERAL ASSEMBLY RECOGNIZES
    11     THAT IT IS IN THE BEST INTEREST OF ITS CITIZENS TO PROVIDE
    12     PHARMACEUTICAL ASSISTANCE IN A REASONABLE AND COST-EFFICIENT
    13     MANNER.
    14         (6)  DRUG PRICE INFLATION HAS CAUSED AN INCREASE IN THE
    15     AMOUNT OF PUBLIC FUNDS EXPENDED BY PACE AND GENERAL
    16     ASSISTANCE.
    17  SECTION 702.  DEFINITIONS.
    18     THE FOLLOWING WORDS AND PHRASES WHEN USED IN THIS CHAPTER
    19  SHALL HAVE THE MEANINGS GIVEN TO THEM IN THIS SECTION UNLESS THE
    20  CONTEXT CLEARLY INDICATES OTHERWISE:
    21     "AVERAGE MANUFACTURER PRICE (AMP)."  WITH RESPECT TO A
    22  COVERED PRESCRIPTION DRUG OF THE MANUFACTURER FOR A CALENDAR
    23  QUARTER, THE AVERAGE UNIT PRICE PAID TO THE MANUFACTURER FOR THE
    24  DRUG BY WHOLESALERS FOR DRUGS DISTRIBUTED TO THE RETAIL PHARMACY
    25  CLASS OF TRADE, EXCEPT FOR DIRECT SALES TO HOSPITALS, HEALTH
    26  MAINTENANCE ORGANIZATIONS AND WHOLESALERS WHERE THE DRUG IS
    27  RELABELED UNDER THAT DISTRIBUTOR'S NATIONAL DRUG CODE NUMBER.
    28  FEDERAL SUPPLY SCHEDULE PRICES SHALL NOT BE INCLUDED IN THE
    29  CALCULATION OF AMP. THE TERM INCLUDES CASH DISCOUNTS AND ALL
    30  OTHER PRICE REDUCTIONS, OTHER THAN REBATES UNDER THIS ACT AND
    19950H0544B4238                 - 42 -

     1  SECTION 1927 OF TITLE XIX OF THE SOCIAL SECURITY ACT (PUBLIC LAW
     2  74-271, 42 U.S.C. § 301 ET SEQ.), ADDED NOVEMBER 5, 1990 (PUBLIC
     3  LAW 101-508, TITLE IV, SECTION 4401(A)(3), 104 STAT. 1388-143),
     4  WHICH REDUCE THE ACTUAL PRICE PAID. FOR BUNDLED OR CAPITATED
     5  SALES, THE ALLOCATION OF THE DISCOUNT SHALL BE MADE
     6  PROPORTIONATELY TO THE DOLLAR VALUE OF THE UNITS OF EACH COVERED
     7  PRESCRIPTION DRUG SOLD UNDER THE BUNDLED OR CAPITATED
     8  ARRANGEMENT. THE AMP FOR A QUARTER SHALL BE ADJUSTED BY THE
     9  MANUFACTURER IF CUMULATIVE DISCOUNTS OR OTHER ARRANGEMENTS
    10  SUBSEQUENTLY ADJUST THE PRICES ACTUALLY REALIZED.
    11     "BUNDLED OR CAPITATED SALES."  THE PACKAGING OF DRUGS OF
    12  DIFFERENT TYPES WHERE:
    13         (1)  THE CONDITION OF REBATE OR DISCOUNT IS THAT MORE
    14     THAN ONE DRUG TYPE IS PURCHASED; OR
    15         (2)  THE RESULTING DISCOUNT OR REBATE IS GREATER THAN
    16     THAT WHICH WOULD HAVE BEEN RECEIVED HAD THE DRUG PRODUCTS
    17     BEEN PURCHASED SEPARATELY.
    18     "CONSUMER PRICE INDEX-URBAN" OR "CPI-U."  A PRICE INDEX
    19  COMPILED BY THE BUREAU OF LABOR STATISTICS OF THE UNITED STATES
    20  DEPARTMENT OF LABOR FOR MEASURING THE AVERAGE CHANGE IN THE
    21  PRICES PAID BY URBAN CONSUMERS FOR A FIXED MARKET BASKET OF
    22  SERVICES.
    23     "COVERED PRESCRIPTION DRUG."  A LEGEND DRUG, INSULIN, AN
    24  INSULIN SYRINGE OR AN INSULIN NEEDLE ELIGIBLE FOR PAYMENT BY THE
    25  COMMONWEALTH UNDER PACE, PACENET OR DESIGNATED PHARMACEUTICAL
    26  PROGRAMS.
    27     "DEPOT PRICE."  THE PRICE AVAILABLE TO ANY DEPOT OF THE
    28  FEDERAL GOVERNMENT FOR PURCHASE OF DRUGS FROM THE MANUFACTURER
    29  THROUGH THE DEPOT SYSTEM OF PROCUREMENT.
    30     "DESIGNATED PHARMACEUTICAL PROGRAMS."  THE GENERAL ASSISTANCE
    19950H0544B4238                 - 43 -

     1  PROGRAM AND THE SPECIAL PHARMACEUTICAL BENEFIT PROGRAM IN THE
     2  DEPARTMENT OF PUBLIC WELFARE AND THE END STAGE RENAL DIALYSIS
     3  PROGRAM IN THE DEPARTMENT OF HEALTH.
     4     "DIRECT SELLER."  ANY PERSON, PARTNERSHIP, CORPORATION,
     5  INSTITUTION OR ENTITY ENGAGED IN THE SELLING OF PHARMACEUTICAL
     6  PRODUCTS DIRECTLY TO CONSUMERS IN THIS COMMONWEALTH.
     7     "DISTRIBUTOR."  A PRIVATE ENTITY UNDER CONTRACT WITH THE
     8  ORIGINAL LABELER OR HOLDER OF THE NATIONAL DRUG CODE NUMBER TO
     9  MANUFACTURE, PACKAGE OR MARKET THE COVERED PRESCRIPTION DRUG.
    10     "DOING BUSINESS IN THIS COMMONWEALTH."  THE DIRECT OR
    11  INDIRECT SELLING OR THE MAKING OF COVERED PRESCRIPTION DRUGS
    12  AVAILABLE FOR SALE IN A CONTINUOUS AND SYSTEMATIC MANNER WITH
    13  THE REASONABLE EXPECTATION THAT THESE PRODUCTS WILL BE SOLD TO
    14  CONSUMERS IN THIS COMMONWEALTH.
    15     "FDA."  THE FOOD AND DRUG ADMINISTRATION OF THE PUBLIC HEALTH
    16  SERVICE OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES.
    17     "GENERAL ASSISTANCE."  THE GENERAL ASSISTANCE PROGRAM OF THE
    18  DEPARTMENT OF PUBLIC WELFARE OF THE COMMONWEALTH.
    19     "INNOVATOR MULTIPLE-SOURCE DRUGS."  A MULTIPLE-SOURCE DRUG
    20  THAT WAS ORIGINALLY MARKETED UNDER A NEW DRUG APPLICATION
    21  APPROVED BY THE FDA. THE TERM INCLUDES:
    22         (1)  COVERED PRESCRIPTION DRUGS APPROVED UNDER PRODUCT
    23     LICENSE APPROVAL (PLA), ESTABLISHMENT LICENSE APPROVAL (ELA)
    24     OR ANTIBIOTIC DRUG APPROVAL (ADA); AND
    25         (2)  A COVERED PRESCRIPTION DRUG MARKETED BY A CROSS-
    26     LICENSED PRODUCER OR DISTRIBUTOR UNDER THE APPROVED
    27     ABBREVIATED NEW DRUG APPLICATION (ANDA) WHEN THE DRUG PRODUCT
    28     MEETS THIS DEFINITION.
    29     "MANUFACTURER."
    30         (1)  AN ENTITY WHICH IS ENGAGED IN ANY OF THE FOLLOWING:
    19950H0544B4238                 - 44 -

     1             (I)   THE PRODUCTION, PREPARATION, PROPAGATION,
     2         COMPOUNDING, CONVERSION OR PROCESSING OF PRESCRIPTION
     3         DRUG PRODUCTS:
     4                 (A)  DIRECTLY OR INDIRECTLY BY EXTRACTION FROM
     5             SUBSTANCES OF NATURAL ORIGIN;
     6                 (B)  INDEPENDENTLY BY MEANS OF CHEMICAL
     7             SYNTHESIS; OR
     8                 (C)  BY A COMBINATION OF EXTRACTION AND CHEMICAL
     9             SYNTHESIS.
    10             (II)  THE PACKAGING, REPACKAGING, LABELING OR
    11         RELABELING, OR DISTRIBUTION OF PRESCRIPTION DRUG
    12         PRODUCTS.
    13         (2)  THE ENTITY HOLDING LEGAL TITLE TO OR POSSESSION OF
    14     THE NATIONAL DRUG CODE NUMBER FOR THE COVERED PRESCRIPTION
    15     DRUG.
    16         (3)  THE TERM DOES NOT INCLUDE A WHOLESALE DISTRIBUTOR OF
    17     DRUGS, DRUGSTORE CHAIN ORGANIZATION OR RETAIL PHARMACY
    18     LICENSED BY THE COMMONWEALTH.
    19     "NATIONAL DRUG CODE NUMBER."  THE IDENTIFYING DRUG NUMBER
    20  MAINTAINED BY THE FDA. THE COMPLETE ELEVEN DIGIT NUMBER MUST
    21  INCLUDE THE LABELER CODE, PRODUCT CODE AND PACKAGE SIZE CODE.
    22     "NEW DRUG."  A COVERED PRESCRIPTION DRUG APPROVED AS A NEW
    23  DRUG UNDER SECTION 201(P) OF THE FEDERAL FOOD, DRUG, AND
    24  COSMETIC ACT (52 STAT. 1040, 21 U.S.C. § 321(P)).
    25     "NONINNOVATOR MULTIPLE-SOURCE DRUG."  ANY OF THE FOLLOWING:
    26         (1)  A COVERED PRESCRIPTION DRUG WHICH IS NOT AN
    27     INNOVATOR MULTIPLE-SOURCE DRUG APPROVED UNDER AN ABBREVIATED
    28     NEW DRUG APPLICATION (ANDA) OR AN AMENDED ANTIBIOTIC DRUG
    29     APPROVAL (AADA).
    30         (2)  A DRUG THAT HAS BEEN APPROVED FOR SUBSTITUTION UNDER
    19950H0544B4238                 - 45 -

     1     THE ACT OF NOVEMBER 24, 1976 (P.L.1163, NO.259), REFERRED TO
     2     AS THE GENERIC EQUIVALENT DRUG LAW.
     3     "PACE."  THE PROGRAM UNDER CHAPTER 5.
     4     "PACENET."  THE PROGRAM ESTABLISHED UNDER SECTION 519.
     5     "PRIVATE ENTITY."  INCLUDES A FOR-PROFIT ENTITY AND A
     6  NONPROFIT ENTITY.
     7     "PRODUCER PRICE INDEX FOR PHARMACEUTICALS."  THE PRESCRIPTION
     8  DRUG PRODUCER PRICE INDEX COMPILED BY THE BUREAU OF LABOR
     9  STATISTICS OF THE UNITED STATES DEPARTMENT OF LABOR FOR
    10  MEASURING AVERAGE CHANGES IN SELLING PRICES RECEIVED BY DOMESTIC
    11  DRUG MANUFACTURERS.
    12     "PROVIDER."  A LICENSED PHARMACY OR DISPENSING PHYSICIAN
    13  ENROLLED AS A PROVIDER IN PACE, PACENET OR DESIGNATED
    14  PHARMACEUTICAL PROGRAMS.
    15     "REBATE PERIOD."  A CALENDAR QUARTER OR OTHER PERIOD
    16  SPECIFIED BY THE SECRETARY OF AGING WITH RESPECT TO THE PAYMENT
    17  OF REBATES UNDER AN AGREEMENT AS PROVIDED IN SECTION 703.
    18     "SECRETARY."  THE SECRETARY OF AGING OF THE COMMONWEALTH.
    19     "SINGLE-SOURCE DRUGS."  LEGEND DRUG PRODUCTS FOR WHICH THE
    20  FDA HAS NOT APPROVED AN ABBREVIATED NEW DRUG APPLICATION (ANDA).
    21     "UNIT."  A DRUG UNIT IN THE LOWEST IDENTIFIABLE AMOUNT, SUCH
    22  AS TABLET OR CAPSULE FOR SOLID DOSAGE FORMS, MILLILITER FOR
    23  LIQUID FORMS AND GRAM FOR OINTMENTS OR CREAMS. THE MANUFACTURER
    24  SHALL SPECIFY THE UNIT FOR EACH DOSAGE FORM AND STRENGTH OF EACH
    25  COVERED PRESCRIPTION DRUG IN ACCORDANCE WITH THE INSTRUCTIONS
    26  DEVELOPED BY THE HEALTH CARE FINANCING ADMINISTRATION FOR
    27  PURPOSES OF THE FEDERAL MEDICAID REBATE PROGRAM UNDER SECTION
    28  1927 OF TITLE XIX OF THE SOCIAL SECURITY ACT (PUBLIC LAW 74-271,
    29  42 U.S.C. § 301 ET SEQ.).
    30     "WHOLESALER."  ANY PERSON, PARTNERSHIP, CORPORATION,
    19950H0544B4238                 - 46 -

     1  INSTITUTION OR ENTITY TO WHICH THE MANUFACTURER SELLS THE
     2  COVERED PRESCRIPTION DRUG, INCLUDING A PHARMACY OR CHAIN OF
     3  PHARMACIES, BUT THAT DOES NOT RELABEL OR REPACKAGE THE COVERED
     4  PRESCRIPTION DRUG.
     5  SECTION 703.  REBATE AGREEMENT.
     6     (A)  REQUIREMENT.--PACE, PACENET AND DESIGNATED
     7  PHARMACEUTICAL PROGRAMS SHALL NOT REIMBURSE FOR ANY COVERED
     8  PRESCRIPTION DRUG WITHOUT A REBATE AGREEMENT BETWEEN THE
     9  DEPARTMENT AND THE MANUFACTURER OF THE COVERED PRESCRIPTION
    10  DRUG.
    11     (B)  EXCEPTION.--SUBSECTION (A) SHALL NOT APPLY IF THE
    12  AVAILABILITY OF THE DRUG IS ESSENTIAL TO THE HEALTH OF ELIGIBLE
    13  CLAIMANTS AS DETERMINED BY THE DEPARTMENT.
    14     (C)  AGREEMENTS.--MANUFACTURERS OF PRESCRIPTION DRUGS
    15  REIMBURSED UNDER PACE, PACENET AND DESIGNATED PHARMACEUTICAL
    16  PROGRAMS MUST ENTER INTO A REBATE AGREEMENT WITH THE DEPARTMENT
    17  UNDER THIS CHAPTER TO OBTAIN SUCH REIMBURSEMENT. NOTHING IN THIS
    18  CHAPTER SHALL BE DEEMED TO AFFECT OR IMPAIR ANY AGREEMENT MADE
    19  UNDER THE FORMER PROVISIONS OF CHAPTER 6 OF THE ACT OF AUGUST
    20  14, 1991 (P.L.342, NO.36), KNOWN AS THE LOTTERY FUND
    21  PRESERVATION ACT.
    22     (D)  NOTICE.--THE DEPARTMENT SHALL NOTIFY ENROLLED PROVIDERS
    23  OF PACE, PACENET AND DESIGNATED PHARMACEUTICAL PROGRAMS ON AN
    24  ANNUAL BASIS AND AS APPROPRIATE OF ALL MANUFACTURERS WHO HAVE
    25  ENTERED INTO A REBATE AGREEMENT.
    26     (E)  DRUG FORMULARY.--EXCEPT AS PROVIDED IN SECTION 512,
    27  THERE SHALL BE NO DRUG FORMULARY, PRIOR OR RETROACTIVE APPROVAL
    28  SYSTEM OR ANY SIMILAR RESTRICTION IMPOSED ON THE COVERAGE OF
    29  OUTPATIENT DRUGS MADE BY MANUFACTURERS WHO HAVE AGREEMENTS IN
    30  EFFECT WITH THE COMMONWEALTH TO PAY REBATES FOR DRUGS UTILIZED
    19950H0544B4238                 - 47 -

     1  IN PACE AND PACENET, PROVIDED THAT SUCH OUTPATIENT DRUGS WERE
     2  APPROVED FOR MARKETING BY THE FOOD AND DRUG ADMINISTRATION. THIS
     3  SUBSECTION SHALL NOT APPLY TO ANY ACT TAKEN BY THE DEPARTMENT
     4  PURSUANT TO ITS THERAPEUTIC DRUG UTILIZATION REVIEW PROGRAM
     5  UNDER SECTION 505.
     6  SECTION 704.  TERMS OF REBATE AGREEMENT.
     7     (A)  QUARTERLY BASIS.--A REBATE AGREEMENT SHALL REQUIRE ANY
     8  MANUFACTURER OF COVERED PRESCRIPTION DRUGS TO PROVIDE TO THE
     9  DEPARTMENT A REBATE EACH CALENDAR QUARTER IN AN AMOUNT SPECIFIED
    10  IN SECTION 705 FOR COVERED PRESCRIPTION DRUGS OF THE
    11  MANUFACTURER REIMBURSED DURING THE QUARTER. THE REBATE SHALL BE
    12  PAID BY THE MANUFACTURER NOT LATER THAN 30 DAYS AFTER THE DATE
    13  OF RECEIPT OF THE INFORMATION DESCRIBED IN SUBSECTION (B) FOR
    14  THE PERIOD INVOLVED.
    15     (B)  INFORMATION.--
    16         (1)  THE DEPARTMENT SHALL REPORT TO EACH MANUFACTURER,
    17     NOT LATER THAN 60 DAYS AFTER THE END OF EACH CALENDAR
    18     QUARTER, INFORMATION BY ZIP CODE OF PROVIDER ON THE TOTAL
    19     NUMBER OF DOSAGE UNITS OF EACH COVERED PRESCRIPTION DRUG
    20     REIMBURSED UNDER PACE, PACENET AND DESIGNATED PHARMACEUTICAL
    21     PROGRAMS DURING THE QUARTER.
    22         (2)  A MANUFACTURER MAY REVIEW THE INFORMATION PROVIDED
    23     UNDER PARAGRAPH (1) AND VERIFY INFORMATION. ADJUSTMENTS TO
    24     REBATES SHALL BE MADE TO THE EXTENT THAT INFORMATION
    25     INDICATES THAT UTILIZATION WAS GREATER OR LESS THAN THE
    26     AMOUNT PREVIOUSLY SPECIFIED.
    27         (3)  IN THE EVENT THAT, IN ANY QUARTER, A MATERIAL
    28     DISCREPANCY IN THE DEPARTMENT'S INFORMATION IS CERTIFIED BY
    29     THE MANUFACTURER PRIOR TO THE DUE DATE OF THE REBATE, THE
    30     DEPARTMENT AND THE MANUFACTURER SHALL, IN GOOD FAITH, ATTEMPT
    19950H0544B4238                 - 48 -

     1     TO RESOLVE THE DISCREPANCY. IF RESOLUTION IS NOT REACHED
     2     WITHIN 30 DAYS OF RECEIPT OF THE MANUFACTURER'S CERTIFICATION
     3     BY THE DEPARTMENT, THE MANUFACTURER MAY APPEAL THE
     4     DEPARTMENT'S DECISION UNDER THE DEPARTMENT'S FORMAL FAIR
     5     HEARINGS AND APPEALS PROCESS. THE MANUFACTURER SHALL PAY THE
     6     DEPARTMENT THAT PORTION OF THE REBATE AMOUNT WHICH IS NOT
     7     DISPUTED WITHIN THE REQUIRED TIME FRAME UNDER THIS CHAPTER.
     8     ANY BALANCE DUE, PLUS STATUTORY INTEREST, SHALL BE PAID OR
     9     CREDITED BY THE MANUFACTURER OR THE DEPARTMENT BY THE DUE
    10     DATE OF THE NEXT QUARTERLY PAYMENT AFTER RESOLUTION OF THE
    11     DISPUTE.
    12     (C)  MANUFACTURER PROVISION OF PRICE INFORMATION.--
    13         (1)  EACH MANUFACTURER WITH AN AGREEMENT IN EFFECT UNDER
    14     THIS CHAPTER SHALL REPORT THE AVERAGE MANUFACTURER PRICE FOR
    15     ALL COVERED PRESCRIPTION DRUGS PRODUCED BY THAT MANUFACTURER
    16     TO THE DEPARTMENT NOT LATER THAN 30 DAYS AFTER THE LAST DAY
    17     OF EACH QUARTER.
    18         (2)  THE DEPARTMENT SHALL RETAIN THE SERVICES OF AN
    19     INDEPENDENT CONTRACTOR TO SURVEY WHOLESALERS, DIRECT SELLERS
    20     AND MANUFACTURERS THAT DIRECTLY DISTRIBUTE THEIR COVERED
    21     PRESCRIPTION DRUGS, WHEN NECESSARY, TO VERIFY MANUFACTURER
    22     PRICES REPORTED UNDER PARAGRAPH (1). ANY SURVEY CONDUCTED
    23     SHALL NOT REVEAL TO THE DEPARTMENT NOR TO ANY OTHER PERSON OR
    24     ENTITY OTHER THAN THE INDEPENDENT CONTRACTOR THE NAME,
    25     IDENTITY, LOCATION, ACTUAL ACQUISITION INVOICE, OTHER
    26     PROPRIETARY INFORMATION OR ANY INFORMATION FROM WHICH THE
    27     DEPARTMENT MIGHT BE ENABLED TO ASCERTAIN THE NAME, IDENTITY
    28     OR LOCATION OF ANY WHOLESALER, DIRECT SELLER OR PROVIDER SO
    29     SURVEYED UNLESS THE CONTRACTOR SHALL HAVE GATHERED SUFFICIENT
    30     EVIDENCE TO ENABLE THE DEPARTMENT TO BRING CHARGES AGAINST
    19950H0544B4238                 - 49 -

     1     ANY WHOLESALER, DIRECT SELLER OR PROVIDER IN VIOLATION OF
     2     SUBSECTION (D)(3).
     3     (D)  PENALTIES.--THE DEPARTMENT SHALL ADMINISTER PENALTIES AS
     4  FOLLOWS:
     5         (1)  A MANUFACTURER WHO FAILS TO SUPPLY INFORMATION
     6     REQUIRED UNDER SUBSECTION (C)(1) SHALL BE LIABLE FOR A CIVIL
     7     PENALTY IN THE AMOUNT OF 2% OF THE REBATE NEXT REQUIRED TO BE
     8     PAID, PLUS $1,000 FOR EACH DAY THAT THE INFORMATION IS LATE.
     9     IF THE INFORMATION IS NOT REPORTED WITHIN 30 DAYS OF THE DUE
    10     DATE, THE AGREEMENT SHALL BE SUSPENDED FOR SERVICES FURNISHED
    11     AFTER THE END OF THE 30-DAY PERIOD UNTIL THE DATE THE
    12     INFORMATION IS REPORTED OR THE EXPIRATION OF 45 DAYS,
    13     WHICHEVER IS LATER.
    14         (2)  A MANUFACTURER WHO KNOWINGLY SUPPLIES FALSE
    15     INFORMATION THAT IS REQUIRED UNDER SUBSECTION (C)(1) SHALL BE
    16     LIABLE FOR A CIVIL PENALTY IN THE AMOUNT OF $50,000 FOR EACH
    17     ITEM OF FALSE INFORMATION.
    18         (3)  A DIRECT SELLER, MANUFACTURER OR WHOLESALER WHO
    19     REFUSES A REQUEST FOR INFORMATION OR KNOWINGLY PROVIDES FALSE
    20     INFORMATION THAT IS REQUIRED UNDER SUBSECTION (C)(2) SHALL BE
    21     LIABLE FOR A CIVIL PENALTY IN THE AMOUNT OF $50,000.
    22         (4)  PENALTIES COLLECTED UNDER THIS SUBSECTION SHALL BE
    23     DEPOSITED INTO THE FUND.
    24         (5)  ALL CIVIL MONETARY PENALTIES IMPOSED UNDER THIS
    25     CHAPTER ARE IN ADDITION TO OTHER CIVIL OR CRIMINAL PENALTIES.
    26     (E)  CONFIDENTIALITY OF INFORMATION.--INFORMATION DISCLOSED
    27  BY MANUFACTURERS, WHOLESALERS OR DIRECT SELLERS UNDER THIS
    28  CHAPTER IS CONFIDENTIAL AND SHALL NOT BE DISCLOSED BY THE
    29  DEPARTMENT IN A FORM WHICH DISCLOSES THE IDENTITY OF A SPECIFIC
    30  MANUFACTURER, WHOLESALER OR DIRECT SELLER OR THE PRICES CHARGED
    19950H0544B4238                 - 50 -

     1  FOR DRUGS BY THE MANUFACTURER OR WHOLESALER, EXCEPT AS THE
     2  DEPARTMENT DETERMINES TO BE NECESSARY TO CARRY OUT THIS CHAPTER
     3  AND TO PERMIT THE DEPARTMENT OF THE AUDITOR GENERAL AND THE
     4  OFFICE OF STATE INSPECTOR GENERAL TO REVIEW THE INFORMATION
     5  PROVIDED.
     6     (F)  LENGTH OF AGREEMENT.--A REBATE AGREEMENT SHALL REMAIN IN
     7  EFFECT FOR AN INITIAL PERIOD OF NOT LESS THAN ONE YEAR AND SHALL
     8  BE AUTOMATICALLY RENEWED FOR A PERIOD OF NOT LESS THAN ONE YEAR
     9  UNLESS TERMINATED UNDER SUBSECTION (G).
    10     (G)  TERMINATION.--
    11         (1)  THE DEPARTMENT MAY PROVIDE FOR TERMINATION OF A
    12     REBATE AGREEMENT FOR ANY REASON. TERMINATION SHALL NOT BE
    13     EFFECTIVE EARLIER THAN 60 DAYS AFTER THE DATE OF RECEIPT OF
    14     NOTICE OF TERMINATION BY THE MANUFACTURERS.
    15         (2)  A MANUFACTURER MAY TERMINATE A REBATE AGREEMENT FOR
    16     ANY REASON. TERMINATION SHALL NOT BE EFFECTIVE EARLIER THAN
    17     60 DAYS AFTER THE DATE OF RECEIPT OF NOTICE OF TERMINATION BY
    18     THE DEPARTMENT.
    19         (3)  TERMINATION OF THE REBATE AGREEMENT SHALL NOT AFFECT
    20     REBATES DUE UNDER THE AGREEMENT BEFORE THE EFFECTIVE DATE OF
    21     TERMINATION.
    22         (4)  COMMONWEALTH COURT SHALL HAVE ORIGINAL JURISDICTION
    23     OVER CASES OF TERMINATION OF AGREEMENTS UNDER THIS
    24     SUBSECTION. COMMENCEMENT OF AN ACTION UNDER THIS PARAGRAPH
    25     SHALL NOT DELAY THE EFFECTIVE DATE OF TERMINATION.
    26         (5)  IF A REBATE AGREEMENT IS TERMINATED FOR CAUSE,
    27     ANOTHER AGREEMENT WITH THE SAME MANUFACTURER OR A SUCCESSOR
    28     MANUFACTURER MAY NOT BE ENTERED INTO UNTIL A PERIOD OF ONE
    29     YEAR HAS ELAPSED FROM THE DATE OF THE TERMINATION UNLESS THE
    30     DEPARTMENT FINDS GOOD CAUSE FOR AN EARLIER AGREEMENT.
    19950H0544B4238                 - 51 -

     1  SECTION 705.  AMOUNT OF REBATE.
     2     (A)  SINGLE-SOURCE DRUGS AND INNOVATOR MULTIPLE-SOURCE
     3  DRUGS.--WITH RESPECT TO SINGLE-SOURCE DRUGS AND INNOVATOR
     4  MULTIPLE-SOURCE DRUGS, EACH MANUFACTURER SHALL REMIT A REBATE TO
     5  THE COMMONWEALTH. EXCEPT AS OTHERWISE PROVIDED IN THIS SECTION,
     6  THE AMOUNT OF THE REBATE TO THE COMMONWEALTH PER CALENDAR
     7  QUARTER WITH RESPECT TO EACH DOSAGE FORM AND STRENGTH OF SINGLE-
     8  SOURCE DRUGS AND INNOVATOR MULTIPLE-SOURCE DRUGS SHALL BE AS
     9  FOLLOWS:
    10         (1)  FOR QUARTERS BEGINNING AFTER SEPTEMBER 30, 1992, AND
    11     ENDING BEFORE JANUARY 1, 1997, THE PRODUCT OF THE TOTAL
    12     NUMBER OF UNITS OF EACH DOSAGE FORM AND STRENGTH REIMBURSED
    13     BY PACE AND GENERAL ASSISTANCE IN THE QUARTER AND THE
    14     DIFFERENCE BETWEEN THE AVERAGE MANUFACTURER PRICE AND 85% OF
    15     THAT PRICE, AFTER DEDUCTING CUSTOMARY PROMPT PAYMENT
    16     DISCOUNTS, FOR THE QUARTER.
    17         (2)  FOR QUARTERS BEGINNING AFTER DECEMBER 31, 1996, THE
    18     PRODUCT OF THE TOTAL NUMBER OF UNITS OF EACH DOSAGE FORM AND
    19     STRENGTH REIMBURSED BY PACE, PACENET AND DESIGNATED
    20     PHARMACEUTICAL PROGRAMS IN THE QUARTER AND THE DIFFERENCE
    21     BETWEEN THE AVERAGE MANUFACTURER PRICE AND 83% OF THAT PRICE,
    22     AFTER DEDUCTING CUSTOMARY PROMPT PAYMENT DISCOUNTS.
    23     (B)  REBATE FOR OTHER DRUGS.--
    24         (1)  THE AMOUNT OF THE REBATE TO THE COMMONWEALTH FOR A
    25     CALENDAR QUARTER WITH RESPECT TO COVERED PRESCRIPTION DRUGS
    26     WHICH ARE NONINNOVATOR MULTIPLE-SOURCE DRUGS SHALL BE EQUAL
    27     TO THE PRODUCT OF:
    28             (I)  THE APPLICABLE PERCENTAGE OF THE AVERAGE
    29         MANUFACTURER PRICE, AFTER DEDUCTING CUSTOMARY PROMPT
    30         PAYMENT DISCOUNTS, FOR EACH DOSAGE FORM AND STRENGTH OF
    19950H0544B4238                 - 52 -

     1         SUCH DRUGS FOR THE QUARTER; AND
     2             (II)  THE NUMBER OF UNITS OF SUCH FORM AND DOSAGE
     3         REIMBURSED BY PACE AND GENERAL ASSISTANCE IN THE QUARTER.
     4         (2)  FOR THE PURPOSES OF PARAGRAPH (1), THE APPLICABLE
     5     PERCENTAGE FOR CALENDAR QUARTERS BEGINNING AFTER SEPTEMBER
     6     30, 1992, AND ENDING BEFORE JANUARY 1, 1997, IS 11%.
     7     (C)  REVISED REBATE FOR OTHER DRUGS.--BEGINNING AFTER
     8  DECEMBER 31, 1996:
     9         (1)  THE AMOUNT OF THE REBATE TO THE COMMONWEALTH FOR A
    10     CALENDAR QUARTER WITH RESPECT TO COVERED PRESCRIPTION DRUGS
    11     WHICH ARE NONINNOVATOR MULTIPLE-SOURCE DRUGS SHALL BE THE
    12     GREATER OF THE PRODUCT OF:
    13             (I)  THE APPLICABLE PERCENTAGE OF THE AVERAGE
    14         MANUFACTURER PRICE, AFTER DEDUCTING CUSTOMARY PROMPT
    15         PAYMENT DISCOUNTS, FOR EACH DOSAGE FORM AND STRENGTH OF
    16         SUCH DRUGS FOR THE QUARTER; AND
    17             (II)  THE NUMBER OF UNITS OF SUCH FORM AND DOSAGE
    18         REIMBURSED BY PACE, PACENET AND DESIGNATED PHARMACEUTICAL
    19         PROGRAMS IN THE QUARTER.
    20         (2)  FOR PURPOSES OF PARAGRAPH (1), THE APPLICABLE
    21     PERCENTAGE IS 17%.
    22     (D)  DRUGS APPROVED AFTER ACT TAKES EFFECT.--IN THE CASE OF A
    23  COVERED OUTPATIENT DRUG APPROVED FOR MARKETING AFTER THE
    24  EFFECTIVE DATE OF THE ACT OF AUGUST 14, 1991 (P.L.342, NO.36),
    25  KNOWN AS THE LOTTERY FUND PRESERVATION ACT, ANY REFERENCE TO
    26  JANUARY 1, 1991, SHALL BE A REFERENCE TO THE FIRST DAY OF THE
    27  FIRST MONTH DURING WHICH THE DRUG WAS MARKETED.
    28  SECTION 706.  EXCESSIVE PHARMACEUTICAL PRICE INFLATION DISCOUNT.
    29     (A)  GENERAL RULE.--A DISCOUNT SHALL BE PROVIDED TO THE
    30  DEPARTMENT FOR ALL COVERED PRESCRIPTION DRUGS. THE DISCOUNT
    19950H0544B4238                 - 53 -

     1  SHALL BE CALCULATED AS FOLLOWS:
     2         (1)  FOR EACH QUARTER FOR WHICH A REBATE UNDER SECTION
     3     705(A) AND (B) IS TO BE PAID AFTER DECEMBER 31, 1991, AND
     4     BEFORE JANUARY 1, 1997, THE AVERAGE MANUFACTURER PRICE FOR
     5     EACH DOSAGE FORM AND STRENGTH OF A COVERED PRESCRIPTION DRUG
     6     SHALL BE COMPARED TO THE AVERAGE MANUFACTURER PRICE FOR THE
     7     SAME FORM AND STRENGTH IN THE PREVIOUS CALENDAR YEAR, AND A
     8     PERCENTAGE INCREASE SHALL BE CALCULATED.
     9         (2)  FOR EACH QUARTER UNDER PARAGRAPH (1), THE AVERAGE
    10     PERCENTAGE INCREASE IN THE PRODUCER PRICE INDEX FOR
    11     PHARMACEUTICALS OVER THE SAME QUARTER IN THE PREVIOUS
    12     CALENDAR YEAR SHALL BE CALCULATED.
    13         (3)  IF THE CALCULATION UNDER PARAGRAPH (1) IS GREATER
    14     THAN THE CALCULATION UNDER PARAGRAPH (2), THE DISCOUNT AMOUNT
    15     FOR EACH QUARTER SHALL BE EQUAL TO THE PRODUCT OF:
    16             (I)  THE DIFFERENCE BETWEEN THE CALCULATIONS UNDER
    17         PARAGRAPHS (1) AND (2); AND
    18             (II)  THE TOTAL NUMBER OF UNITS OF EACH DOSAGE FORM
    19         AND STRENGTH REIMBURSED BY PACE AND GENERAL ASSISTANCE
    20         AND THE AVERAGE MANUFACTURER PRICE REPORTED BY THE
    21         MANUFACTURER UNDER SECTION 704(C)(1).
    22     (B)  REVISED GENERAL RULE.--A DISCOUNT SHALL BE PROVIDED TO
    23  THE DEPARTMENT FOR ALL COVERED PRESCRIPTION DRUGS. THE DISCOUNT
    24  SHALL BE CALCULATED AS FOLLOWS:
    25         (1)  FOR EACH QUARTER FOR WHICH A REBATE UNDER SECTION
    26     705(A) AND (C) IS TO BE PAID AFTER DECEMBER 31, 1996, THE
    27     AVERAGE MANUFACTURER PRICE FOR EACH DOSAGE FORM AND STRENGTH
    28     OF A COVERED PRESCRIPTION DRUG SHALL BE COMPARED TO THE
    29     AVERAGE MANUFACTURER PRICE FOR THE SAME FORM AND STRENGTH IN
    30     THE PREVIOUS CALENDAR YEAR AND A PERCENTAGE INCREASE SHALL BE
    19950H0544B4238                 - 54 -

     1     CALCULATED.
     2         (2)  FOR EACH QUARTER UNDER PARAGRAPH (1), THE AVERAGE
     3     PERCENTAGE INCREASE IN THE CONSUMER PRICE INDEX-URBAN OVER
     4     THE SAME QUARTER IN THE PREVIOUS CALENDAR YEAR SHALL BE
     5     CALCULATED.
     6         (3)  IF THE CALCULATION UNDER PARAGRAPH (1) IS GREATER
     7     THAN THE CALCULATION UNDER PARAGRAPH (2), THE DISCOUNT AMOUNT
     8     FOR EACH QUARTER SHALL BE EQUAL TO THE PRODUCT OF:
     9             (I)  THE DIFFERENCE BETWEEN THE CALCULATIONS UNDER
    10         PARAGRAPHS (1) AND (2); AND
    11             (II)  THE TOTAL NUMBER OF UNITS OF EACH DOSAGE FORM
    12         AND STRENGTH REIMBURSED BY PACE, PACENET AND DESIGNATED
    13         PHARMACEUTICAL PROGRAMS AND THE AVERAGE MANUFACTURER
    14         PRICE REPORTED BY THE MANUFACTURER UNDER SECTION
    15         704(C)(1).
    16     (C)  NEW BI-MARKETED DRUGS.--FOR COVERED PRESCRIPTION DRUGS
    17  THAT HAVE NOT BEEN MARKETED FOR A FULL CALENDAR YEAR, SUBSECTION
    18  (A) SHALL APPLY AFTER THE COVERED PRESCRIPTION DRUG HAS BEEN ON
    19  THE MARKET FOR FOUR CONSECUTIVE QUARTERS. THE DRUG'S INITIAL
    20  AVERAGE MANUFACTURER PRICE SHALL BE BASED ON THE FIRST DAY OF
    21  THE FIRST QUARTER THAT THE DRUG WAS MARKETED.
    22  SECTION 707.  LOWERED BEST PRICE.
    23     (A)  GENERAL RULE.--IF THE REBATE UNDER SECTION 705 AND THE
    24  DISCOUNT UNDER SECTION 706 WOULD ESTABLISH A LOWERED FEDERAL
    25  BEST PRICE, AS DEFINED IN SECTION 1927(C)(1)(C) OF THE SOCIAL
    26  SECURITY ACT (PUBLIC LAW 74-271, 42 U.S.C. § 1396R-8(C)(1)(C)),
    27  THE MANUFACTURER SHALL BE LIABLE FOR A TOTAL REBATE AND DISCOUNT
    28  IN AN AMOUNT THAT DOES NOT REDUCE THE FEDERAL BEST PRICE FOR
    29  THAT COVERED PRESCRIPTION DRUG.
    30     (B)  PROCEDURE.--ANY CLAIM BY A MANUFACTURER THAT A REBATE
    19950H0544B4238                 - 55 -

     1  WOULD ESTABLISH A LOWER FEDERAL BEST PRICE UNDER SUBSECTION (A)
     2  SHALL BE VERIFIED IN WRITING BY A DEPARTMENT-APPROVED
     3  INDEPENDENT PUBLIC ACCOUNTING FIRM WITHIN 45 DAYS OF THE END OF
     4  THE QUARTER FOR WHICH THE CLAIM IS ASSERTED. THE INFORMATION
     5  PROVIDED TO THE PUBLIC ACCOUNTING FIRM SHALL REMAIN
     6  CONFIDENTIAL.
     7     (C)  CIVIL PENALTY.--A MANUFACTURER WHICH PROVIDES FALSE
     8  INFORMATION UNDER THIS SECTION SHALL BE LIABLE FOR A CIVIL
     9  PENALTY IN AN AMOUNT NOT TO EXCEED $50,000. EACH ITEM OF FALSE
    10  INFORMATION CONSTITUTES A SEPARATE VIOLATION.
    11  SECTION 708.  EXEMPTION.
    12     SECTION 521(A) SHALL NOT APPLY TO REBATES UNDER THIS CHAPTER.
    13  SECTION 709.  DISPOSITION OF FUNDS.
    14     (A)  PACE AND PACENET.--MONEY RECEIVED UNDER THIS CHAPTER IN
    15  CONNECTION WITH PACE AND PACENET SHALL BE DEPOSITED IN THE
    16  PHARMACEUTICAL ASSISTANCE CONTRACT FOR THE ELDERLY FUND.
    17     (B)  DESIGNATED PHARMACEUTICAL PROGRAMS.--MONEY RECEIVED
    18  UNDER THIS CHAPTER IN CONNECTION WITH DESIGNATED PHARMACEUTICAL
    19  PROGRAMS SHALL BE TREATED AS A REFUND OF EXPENDITURES TO THE
    20  APPROPRIATION WHICH ORIGINALLY PROVIDED THE FUNDING FOR THE
    21  PHARMACEUTICAL PURCHASE.
    22                             CHAPTER 9
    23                      TRANSPORTATION SERVICES
    24  SECTION 901.  DEFINITIONS.
    25     THE FOLLOWING WORDS AND PHRASES WHEN USED IN THIS CHAPTER
    26  SHALL HAVE THE MEANINGS GIVEN TO THEM IN THIS SECTION UNLESS THE
    27  CONTEXT CLEARLY INDICATES OTHERWISE:
    28     "SHARED-RIDE PUBLIC TRANSPORTATION SERVICES."  DEMAND-
    29  RESPONSIVE TRANSPORTATION THAT IS AVAILABLE TO THE GENERAL
    30  PUBLIC, OPERATES ON A NONFIXED ROUTE BASIS AND CHARGES A FARE TO
    19950H0544B4238                 - 56 -

     1  ALL RIDERS. FOR TRANSPORTATION TO BE INCLUDED IN THIS
     2  DEFINITION, THE FIRST FARE PAYING PASSENGERS TO ENTER THE PUBLIC
     3  TRANSPORTATION VEHICLE MUST NOT REFUSE TO SHARE THE VEHICLE WITH
     4  OTHER PASSENGERS DURING A GIVEN TRIP. THE TERM EXCLUDES
     5  EXCLUSIVE RIDE TAXI SERVICE, CHARTER AND SIGHTSEEING SERVICES,
     6  NONPUBLIC TRANSPORTATION, SCHOOL BUS AND LIMOUSINE SERVICES.
     7  SECTION 902.  DEPARTMENT OF TRANSPORTATION.
     8     THE DEPARTMENT OF TRANSPORTATION HAS THE POWER AND DUTY TO
     9  MAKE GRANTS FROM THE FUND TO TRANSPORTATION COMPANIES, COUNTY
    10  TRANSPORTATION SYSTEMS AND LOCAL TRANSPORTATION ORGANIZATIONS TO
    11  PAY ESTIMATED TRANSIT LOSSES RESULTING FROM PROVIDING FREE
    12  SERVICE OR LOCAL COMMON CARRIER MASS TRANSPORTATION SYSTEMS TO
    13  PERSONS 65 YEARS OF AGE OR OLDER WHEN PASSAGE IS ON FIXED ROUTE
    14  PUBLIC TRANSPORTATION SERVICES DURING NONPEAK RIDING HOURS AND
    15  ON HOLIDAYS AND WEEKENDS. REIMBURSEMENT SHALL BE AS FOLLOWS:
    16         (1)  THE LOSSES RESULTING FROM GRANTING SERVICE ON MASS
    17     TRANSPORTATION SYSTEMS SHALL BE REIMBURSABLE AT 100% OF THE
    18     SYSTEM'S AVERAGE OR BASE FARE, WHICHEVER IS LESS, MULTIPLIED
    19     BY THE NUMBER OF TRIPS MADE BY SENIOR CITIZENS PARTICIPATING
    20     IN THE FREE TRANSIT PROGRAM.
    21         (2)  NOTWITHSTANDING PARAGRAPH (1), THE DEPARTMENT SHALL,
    22     WITH THE APPROVAL OF THE GOVERNOR'S OFFICE OF THE BUDGET,
    23     REIMBURSE TRANSPORTATION COMPANIES OR LOCAL TRANSPORTATION
    24     ORGANIZATIONS FOR 100% OF THE LOSSES RESULTING FROM SENIOR
    25     CITIZEN TRANSFER TRIPS INCURRED UNDER THE CONDITIONS OF THIS
    26     SUBSECTION.
    27         (3)  MONEY APPROPRIATED FROM THE GENERAL FUND TO THE
    28     DEPARTMENT OF TRANSPORTATION TO AUGMENT FIXED ROUTE PUBLIC
    29     TRANSPORTATION SERVICES UNDER THIS SECTION SHALL BE GRANTED
    30     TO TRANSPORTATION PROVIDERS AT THE DISCRETION OF THE
    19950H0544B4238                 - 57 -

     1     DEPARTMENT OF TRANSPORTATION.
     2  SECTION 903.  COMMUTER RAIL FARE.
     3     WITH REGARD TO PASSAGE ON FIXED-ROUTE COMMUTER RAIL LINES,
     4  THE FARE FOR ADULTS 65 YEARS OF AGE OR OLDER WHO DO NOT QUALIFY
     5  AS ELIGIBLE CLAIMANTS UNDER THE PHARMACEUTICAL ASSISTANCE
     6  CONTRACT FOR THE ELDERLY PROGRAM SHALL BE LIMITED TO $1 PER TRIP
     7  BUT ONLY WHEN UTILIZING SUCH TRANSPORTATION SERVICES DURING
     8  NONPEAK RIDING HOURS AND ON HOLIDAYS AND WEEKENDS.
     9  SECTION 904.  SHARED-RIDE TRANSPORTATION.
    10     (A)  PROGRAM GRANTS.--THE DEPARTMENT OF TRANSPORTATION HAS
    11  THE POWER AND DUTY TO ADMINISTER, UTILIZING A FIXED AMOUNT OF
    12  MONEY FROM THE FUND AS PROVIDED THROUGH EXECUTIVE AUTHORIZATIONS
    13  BY THE GOVERNOR, A PROGRAM PROVIDING SHARED-RIDE PUBLIC
    14  TRANSPORTATION SERVICES FOR ADULTS 65 YEARS OF AGE OR OLDER.
    15  INDIVIDUALS UTILIZING SHARED-RIDE PUBLIC TRANSPORTATION SERVICES
    16  FOR OLDER ADULTS SHALL CONTRIBUTE 15% OF THE INDIVIDUAL FARE AND
    17  85% OF THE INDIVIDUAL FARE SHALL BE REIMBURSED BY THE FUND.
    18     (B)  REGULATIONS.--THE DEPARTMENT OF TRANSPORTATION SHALL
    19  PROMULGATE REGULATIONS NECESSARY TO CARRY OUT THE PURPOSES OF
    20  THIS SECTION, INCLUDING REGULATIONS THAT PERMIT LIMITED
    21  REIMBURSEMENT FOR SHARED-RIDE PUBLIC TRANSPORTATION SERVICES
    22  PROVIDING ACCESS TO AND FROM PUBLIC AIRPORTS. THE DEPARTMENT OF
    23  TRANSPORTATION, IN CONSULTATION WITH THE PENNSYLVANIA PUBLIC
    24  UTILITY COMMISSION AND THE DEPARTMENT, SHALL ESTABLISH
    25  REASONABLE PER MILE OR TRIP FARE LIMITS FOR PURPOSES OF
    26  SUBSECTION (A). IN ACCORDANCE WITH SECTION 2203-A(A)(27) OF THE
    27  ACT OF APRIL 9, 1929 (P.L.177, NO.175), KNOWN AS THE
    28  ADMINISTRATIVE CODE OF 1929, NO REGULATION SHALL TAKE EFFECT
    29  UNTIL SUBMITTED TO THE DEPARTMENT FOR COMMENT.
    30     (C)  COORDINATED TRANSPORTATION PLANS.--THE DEPARTMENT OF
    19950H0544B4238                 - 58 -

     1  TRANSPORTATION SHALL REQUIRE THAT EACH TRANSPORTATION PROVIDER
     2  OR DESIGNATED COORDINATOR, WHICHEVER IS APPROPRIATE, ANNUALLY
     3  DEVELOP A COORDINATED TRANSPORTATION PLAN WHICH SHALL INCLUDE,
     4  BUT NOT BE LIMITED TO, ANY CURRENT FIXED-ROUTE SYSTEM AND
     5  SHARED-RIDE PROGRAMS. ALL PLANS MUST BE SUBMITTED TO AND
     6  APPROVED BY THE DEPARTMENT NO LATER THAN JUNE 1 OF EACH FISCAL
     7  YEAR.
     8     (D)  OTHER FORMS OF ASSISTANCE.--ANY ELIGIBLE CLAIMANT WHOSE
     9  TRANSPORTATION SERVICES ARE COVERED IN PART BY ANY OTHER PLAN OF
    10  ASSISTANCE MAY BE REQUIRED TO RECEIVE REDUCED TRANSPORTATION
    11  ASSISTANCE UNDER THE PROVISIONS OF THIS CHAPTER.
    12     (E)  ENTITLEMENT NOT CREATED.--NOTHING IN THIS CHAPTER
    13  CREATES OR PROVIDES ANY INDIVIDUAL WITH AN ENTITLEMENT TO
    14  SERVICES.
    15  SECTION 905.  GRANTS.
    16     GRANTS MAY BE MADE UNDER THIS CHAPTER WITH REFERENCE TO ANY
    17  APPROPRIATE PROJECT, IRRESPECTIVE OF WHEN IT WAS FIRST COMMENCED
    18  OR CONSIDERED AND REGARDLESS OF WHETHER COSTS WITH RESPECT TO
    19  THE PROJECT HAVE BEEN INCURRED PRIOR TO THE TIME THE GRANT IS
    20  APPLIED FOR OR MADE.
    21                             CHAPTER 21
    22                      MISCELLANEOUS PROVISIONS
    23  SECTION 2101.  SAVINGS.
    24     THIS ACT DOES NOT AFFECT ANY ACT DONE, REGULATION
    25  PROMULGATED, LIABILITY INCURRED OR RIGHT ACCRUED OR VESTED OR
    26  AFFECT ANY CIVIL OR CRIMINAL PROCEEDING PENDING OR TO BE
    27  COMMENCED TO ENFORCE ANY RIGHT OR PENALTY OR PUNISH ANY OFFENSE
    28  UNDER ANY STATUTE OR PART OF A STATUTE REPEALED BY THIS ACT.
    29  SECTION 2102.  ANNUAL REPORT TO GENERAL ASSEMBLY.
    30     (A)  SUBMISSION OF REPORT.--THE DEPARTMENT SHALL SUBMIT A
    19950H0544B4238                 - 59 -

     1  REPORT NO LATER THAN APRIL 1 OF EACH YEAR TO THE CHAIRMAN AND
     2  MINORITY CHAIRMAN OF THE AGING AND YOUTH COMMITTEE OF THE
     3  SENATE, THE CHAIRMAN AND MINORITY CHAIRMAN OF THE AGING AND
     4  YOUTH COMMITTEE OF THE HOUSE OF REPRESENTATIVES AND THE
     5  PHARMACEUTICAL ASSISTANCE REVIEW BOARD.
     6     (B)  COLLECTION OF DATA.--THE DEPARTMENT SHALL MAINTAIN
     7  MONTHLY STATISTICAL RECORDS ON PACE AND PACENET, INCLUDING THE
     8  LEVEL OF PARTICIPATION AND ANY PATTERNS OF UNUSUAL DRUG USAGE
     9  FOR PURPOSES OF FORMULATING THE ANNUAL REPORT.
    10     (C)  INFORMATION FOR INCLUSION IN ANNUAL REPORT.--THE ANNUAL
    11  REPORT SHALL CONTAIN, BUT NOT BE LIMITED TO, ALL INFORMATION
    12  RELATING TO:
    13         (1)  THE NUMBER OF PERSONS SERVED BY PACE AND PACENET AND
    14     THEIR COUNTIES OF RESIDENCE.
    15         (2)  A BREAKDOWN OF THE NUMBERS AND KINDS OF
    16     PHARMACEUTICALS USED.
    17         (3)  THE COST OF PRESCRIPTIONS.
    18         (4)  AN ESTIMATE OF ACTUAL EXPENSES INCURRED BY
    19     PHARMACISTS PARTICIPATING IN THE PROGRAM.
    20         (5)  THE RESULTS OBTAINED BY THE DRUG EDUCATION PROGRAM
    21     UNDER SECTION 522.
    22         (6)  INFORMATION REGARDING THE OPERATION OF THE
    23     THERAPEUTIC DRUG UTILIZATION REVIEW SYSTEM FOR THE PRIOR
    24     CALENDAR YEAR, WHICH SHALL INCLUDE, AT A MINIMUM:
    25             (I)  THE SCOPE OF PHYSICIAN AND PHARMACIST
    26         PARTICIPATION IN THE SYSTEM.
    27             (II)  A DESCRIPTION OF CLAIMANT RESPONSE TO THE
    28         SYSTEM.
    29             (III)  DATA FOR EACH MONTH OF THE COVERED PERIOD
    30         REGARDING THE NUMBER OF PRESCRIPTION REVISIONS BASED ON
    19950H0544B4238                 - 60 -

     1         UTILIZATION REVIEW, INCLUDING DRUG INFORMATION, COST
     2         SAVINGS AND THE POLICY USED BY THE DEPARTMENT TO MAKE
     3         UTILIZATION REVIEW DECISIONS.
     4         (7)  INFORMATION ON THE EXISTENCE AND SCOPE OF FRAUDULENT
     5     ACTIVITY AND VIOLATIONS OF THIS ACT BY PROVIDERS
     6     PARTICIPATING IN PACE AND PACENET.
     7         (8)  INFORMATION REGARDING THE FINANCIAL STATUS OF PACE
     8     AND PACENET, INCLUDING, BUT NOT LIMITED TO, THE ADEQUACY OF
     9     ANY APPLICABLE DEDUCTIBLE AND COPAYMENT LEVELS, BASED UPON
    10     THE FINANCIAL EXPERIENCE AND PROJECTIONS OF PACE AND PACENET.
    11     SECTION 3.  THE PROVISIONS OF THIS ACT ARE SEVERABLE. IF ANY
    12  PROVISION OF THIS ACT OR ITS APPLICATION TO ANY PERSON OR
    13  CIRCUMSTANCE IS HELD INVALID, THE INVALIDITY SHALL NOT AFFECT
    14  OTHER PROVISIONS OR APPLICATIONS OF THIS ACT WHICH CAN BE GIVEN
    15  EFFECT WITHOUT THE INVALID PROVISION OR APPLICATION.
    16     SECTION 4.  (A)  THE ACT OF AUGUST 14, 1991 (P.L.342, NO.36),
    17  KNOWN AS THE LOTTERY FUND PRESERVATION ACT, IS REPEALED.
    18     (B)  ALL OTHER ACTS AND PARTS OF ACTS ARE REPEALED INSOFAR AS
    19  THEY ARE INCONSISTENT WITH THIS ACT.
    20     SECTION 5.  THIS ACT SHALL TAKE EFFECT AS FOLLOWS:
    21         (1)  THE AMENDMENT OR ADDITION OF SECTIONS 303 AND 306 OF
    22     THE ACT SHALL TAKE EFFECT IN 60 DAYS.
    23         (2)  THE REMAINDER OF THIS ACT SHALL TAKE EFFECT
    24     IMMEDIATELY.




    L30L72JLW/19950H0544B4238       - 61 -